-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 UKkYMUUgCmW+65Poy3yAGYenA0iE5cWsLRC7vk9WTh4kTBeXCC/tW9OOY/46XI3L
 HQU5bEVIhazVryhZV9m+5A==

<SEC-DOCUMENT>0000009892-00-000006.txt : 20000331
<SEC-HEADER>0000009892-00-000006.hdr.sgml : 20000331
ACCESSION NUMBER:		0000009892-00-000006
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		9
CONFORMED PERIOD OF REPORT:	19991231
FILED AS OF DATE:		20000330

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BARD C R INC /NJ/
		CENTRAL INDEX KEY:			0000009892
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				221454160
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		
		SEC FILE NUMBER:	001-06926
		FILM NUMBER:		584595

	BUSINESS ADDRESS:	
		STREET 1:		730 CENTRAL AVE
		CITY:			MURRAY HILL
		STATE:			NJ
		ZIP:			07974
		BUSINESS PHONE:		9082778000

	MAIL ADDRESS:	
		STREET 1:		730 CENTRAL AVENUE
		CITY:			MURRAY HILL
		STATE:			NJ
		ZIP:			07974
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<TEXT>

<HTML>
<HEAD>
<TITLE>10K992</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="Garamond"><P ALIGN="CENTER">SECURITIES AND EXCHANGE COMMISSION</P>
<P ALIGN="CENTER">Washington, D. C. 20549</P>
<P ALIGN="CENTER">FORM 10-K</P>
<P ALIGN="CENTER">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF</P>
<P ALIGN="CENTER">THE SECURITIES EXCHANGE ACT OF 1934</P>
<P ALIGN="CENTER">For the fiscal year ended December 31, 1999</P>
<P ALIGN="CENTER">Commission File Number 1-6926</P>
<P ALIGN="CENTER">C. R. BARD, INC.</P>
<P ALIGN="CENTER">(Exact name of registrant as specified in its
charter)</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=624>
<TR><TD WIDTH="50%" VALIGN="TOP">
<P ALIGN="CENTER"><U><FONT FACE="Garamond">New Jersey</U></FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">22-1454160</U></FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">(State of incorporation)</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">(I.R.S. Employer
Identification No.)</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="CENTER">730 Central Avenue, Murray Hill,
New Jersey 07974</P>
<P ALIGN="CENTER">(Address of principal executive offices)</P>
<P ALIGN="CENTER">Registrant's telephone number, including area code: (908) 277-8000</P>
<P ALIGN="CENTER">Securities registered pursuant to Section 12(b) of the Act:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=624>
<TR><TD WIDTH="50%" VALIGN="TOP">
<P ALIGN="CENTER"><U><FONT FACE="Garamond">Title of each class</U></FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">Name of each exchange on which registered</U></FONT></TD>
</TR>
<TR><TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">Common Stock - $.25 par value</FONT></TD>
<TD WIDTH="50%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">New York Stock Exchange</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>&#9;</P>
<P>Securities registered pursuant to Section 12(g) of the Act: None</P>
<P ALIGN="JUSTIFY">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes<U> X </U>No<U> </P>
</U><P ALIGN="JUSTIFY">Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any amendments to this Form 10-K. [ X ]</P>
<P ALIGN="JUSTIFY">The aggregate market value of the voting stock held by nonaffiliates of the registrant was approximately $2,007,837,851 based on the closing price of stock traded on the New York Stock Exchange on February 29, 2000. As of February 29,
2000, there were 50,831,338 shares of Common Stock, $.25 par value per share, outstanding.</P>
<P ALIGN="JUSTIFY">The company's definitive Proxy Statement dated March 10, 2000 has been incorporated by reference with respect to certain information contained therein in Part III and Part IV of this Form 10-K.</P>
<P ALIGN="JUSTIFY">The exhibit index is located in Part IV, Item 14, Page IV-1.</P>
<U><P ALIGN="CENTER">PART I</P>
<P ALIGN="JUSTIFY">Item 1.</U> <U>Business</P>
<P ALIGN="JUSTIFY">General Development of Business</P>
</U><P ALIGN="JUSTIFY">C. R. Bard, Inc. (the "company" or "Bard") was
started by Charles Russell Bard in 1907. One of its first medical products
was the silk urethral catheter imported from France. In 1923, the company
was incorporated as C. R. Bard, Inc. and distributed an assortment of
urological and surgical products. Bard became a publicly-traded company in
1963 and five years later was traded on the New York Stock Exchange.</P>
<P ALIGN="JUSTIFY">In 1966, Bard acquired the United States Catheter &amp;
Instrument Co., a supplier of urological and cardiovascular specialty
products. In 1980 Bard acquired its major source of the Foley catheter -
Davol Inc. Numerous other acquisitions were made over the last thirty-five
years broadening Bard's product lines. Today, Bard is a leading
multinational developer,
manufacturer and marketer of health care products.</P>
<P ALIGN="JUSTIFY">1999 sales of $1.036 billion decreased 11% from 1998.
Net income for 1999 totaled $118.1 million compared with $252.3 million in
1998. Basic and diluted earnings per share were $2.31 and $2.28,
respectively in 1999. Basic and diluted earnings per share were $4.54 and
$4.51, respectively, in 1998. </P>
<U><P ALIGN="JUSTIFY">Acquisitions and Dispositions</P>
</U><P ALIGN="JUSTIFY">In 1999 the company completed the sale of its
cardiopulmonary business. This disposition, which resulted in a pretax
gain of $9.2 million ($.12 per share after tax), was part of a series of
strategic dispositions of cardiology businesses announced in 1998. The
first in the series was the company's 1998 cardiac cath lab business. The
company expects to settle in 2000 the purchase price and other adjustments
relating to this transaction. The company does not expect the adjustments
to have an adverse effect on its results of operations.</P>
<P ALIGN="JUSTIFY">Also in 1999, the company entered into an exclusive
agreement with Endologix, Inc., a California-based company that has
developed an endoluminal graft (ELG) used for the minimally invasive
treatment of abdominal aortic aneurysms. The agreement gives Bard exclusive
distribution rights to Endologix's ELG in Europe and Australia and an
exclusive and irrevocable option to acquire, for approximately $45 million,
all of the company's remaining capital stock before the end of the Year 2000.
 Bard paid approximately $34 million primarily for the distribution rights
and the option.</P>
<P ALIGN="JUSTIFY">In 1998 the company reported a pretax gain of $329.2
million ($3.03 per share after tax) on the disposition of its cardiology
businesses and a pretax loss of $17.5 million ($.18 per share after tax)
on the sale of several other product lines (including the loss on the sale
of the Diagnostic Sciences Division.)</P>
<P ALIGN="JUSTIFY">The 1997 financial results include the disposition of
two product lines that resulted in a pretax gain of $22.7 million ($.23 per
share after tax).</P>
<U><P ALIGN="JUSTIFY">Product Group Information</P>
</U><P ALIGN="JUSTIFY">Bard is engaged in the design, manufacture,
packaging, distribution and sale of medical, surgical, diagnostic and
patient care devices. Hospitals, physicians and nursing homes purchase
approximately 90% of the company's products, most of which are used once
and discarded.</P>
<P ALIGN="CENTER">I-1</P>
<P ALIGN="JUSTIFY">The company reports its sales around the concept of
disease state management. Three of Bard</FONT><FONT FACE="WP
TypographicSymbols">=</FONT><FONT FACE="Garamond">s four major product
group categories are: vascular diagnosis and intervention, urological
diagnosis and intervention, and oncological diagnosis and intervention.
In addition the company maintains and grows
its fourth major product group, surgical specialties,
and also has a product group of other ongoing products. The divested
products category contains divested and discontinued product lines.</P>
<P ALIGN="JUSTIFY">The following table sets forth for the last three years
ended December 31, 1999, the approximate percentage contribution by
product line to Bard's consolidated net sales on a worldwide basis.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=531>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">&nbsp;</FONT></TD>
<TD WIDTH="72%" VALIGN="TOP" COLSPAN=5 HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</P>
<U><P ALIGN="CENTER">Years Ended December 31, </U></FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;<U>1999 </U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">1998 </U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Vascular</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">22%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">18%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">16%</FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Urology</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">34%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">29%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">27%</FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Oncology</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">23%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">18%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">16%</FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Surgery</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">16%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">13%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">11%</FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other ongoing products</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">5%</U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">5%</U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">5%</U></FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total ongoing products</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">100%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">83%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">75%</FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Divested products</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">---</U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">17%</U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">25%</U></FONT></TD>
</TR>
<TR><TD WIDTH="28%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net sales</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">100%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">100%</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">100%</FONT></TD>
</TR>
</TABLE>

<U><FONT FACE="Garamond"><P ALIGN="JUSTIFY">Narrative Description of
Business</P>
<P ALIGN="JUSTIFY">General</P>
</U><P ALIGN="JUSTIFY">Historically, Bard has been known for its
products in the urological field, where its Foley catheter is the leading
device for bladder drainage. Bard's largest product group is the urological
diagnosis and intervention category contributing approximately 34% of
consolidated net sales in 1999.</P>
<P ALIGN="JUSTIFY">Bard continually expands its research toward the
improvement of existing products and the development of new ones. It has
pioneered the development of disposable medical products for standardized
procedures.</P>
<U><P ALIGN="JUSTIFY">Vascular Diagnosis and Intervention</U> - Bard's line
of vascular diagnosis and intervention products includes peripheral
angioplasty stents, catheters, guidewires, introducers and accessories,
vena cava filters and biopsy devices; electrophysiology products including
cardiac mapping and electrophysiology laboratory systems, and diagnostic
and temporary pacing
electrode catheters; fabrics and meshes and
implantable blood vessel replacements.</P>
<U><P ALIGN="JUSTIFY">Urological Diagnosis and Intervention</U> - Bard
offers a complete line of urological diagnosis and intervention products
including Foley catheters, procedure kits and trays and related urine
monitoring and collection systems; ureteral stents; and specialty devices
for incontinence, endoscopic procedures and stone removal.</P>
<U><P ALIGN="JUSTIFY">Oncological Diagnosis and Intervention</U> -
Bard</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT
FACE="Garamond">s line of oncological diagnosis and intervention
products include specialty access catheters and ports and
gastroenterological products.</P>
<P ALIGN="CENTER">I-2</P>
<U><P ALIGN="JUSTIFY">Surgical Specialties</U> -
Bard</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT
FACE="Garamond">s surgical specialties products include meshes for
hernia repair; irrigation devices for orthopaedic and laparoscopic
procedures; laparoscopic accessories; and topical hemostasis.</P>
<U><P ALIGN="JUSTIFY">International</U> - Bard markets vascular,
urological, oncological and surgical specialties products throughout the
world. Principal markets are Japan, Canada, the United Kingdom and
continental Europe. Approximately 41% of the sales outside the United
 States are of products manufactured by Bard in its facilities in Canada,
 France, Germany, Malaysia and the United
Kingdom. The balance of the sales are
from products manufactured in the continental United States, Puerto Rico or
Mexico for export. Bard's foreign operations are subject to the usual risks
of doing business abroad, including restrictions on currency transfer,
exchange fluctuations and possible adverse government regulations. See p.
II-26 Note 10 in the Notes to Consolidated Financial Statements for
additional information.</P>
<U><P ALIGN="JUSTIFY">Competition</P>
</U><P ALIGN="JUSTIFY">The company knows of no published statistics
permitting a general industry classification that would be meaningful as
applied to the company's variety of products. However, products sold by the
company are in substantial competition with those of many other firms,
including a number of larger well-established companies. The company
depends more on its consistently
reliable product quality, dependable
service and its ability to develop products to meet market needs than on
patent protection, although some of its products are patented or are the subject of patent applications.</P>
<U><P ALIGN="JUSTIFY">Marketing</P>
</U><P ALIGN="JUSTIFY">The company's products are distributed domestically directly to hospitals and other institutions as well as through numerous hospital/surgical supply and other medical specialty distributors with whom the company has distributor
agreements. In international markets, products are distributed either directly or through distributors with the practice varying by country.
Sales promotion is carried on by
full-time representatives of the company in domestic and international markets.</P>
<P ALIGN="JUSTIFY">Sales to distributors, which supply the company's products to many end users, accounted for approximately 39% of the company's net sales in 1999, and the five largest distributors combined accounted for approximately 71% of such sales.
</P>
<P ALIGN="JUSTIFY">In order to service its customers, both in the U.S. and outside the U.S., the company maintains inventories at distribution facilities in most of its principal marketing areas. Orders are normally shipped within a matter of days after
receipt, except for items temporarily out of stock, and backlog is normally not significant for the company.</P>
<P ALIGN="JUSTIFY">Most of the products sold by the company, whether manufactured by it or by others, are sold under the BARD</FONT><FONT FACE="WP TypographicSymbols">7</FONT><FONT FACE="Garamond"> trade name or trademark or other trademarks owned by the
company. Such products manufactured for the company by outside suppliers are produced according to the company's specifications.</P>
<U><P ALIGN="JUSTIFY">Regulation</P>
</U><P ALIGN="JUSTIFY">The development, manufacture, sale and distribution of the company's products are subject to comprehensive government regulation both within and outside the United States. Government regulation, including detailed inspection of and
controls over, research and laboratory procedures, clinical investigations, manufacturing, marketing, sampling, distribution, record
keeping, storage and </P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">I-3</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="JUSTIFY">disposal practices, substantially increases the time, difficulty and costs incurred in obtaining and maintaining the approval to market newly developed and existing products. Government regulatory actions can result in the seizure or
recall of products, suspension or revocation of the authority necessary for their production and sale, and other civil or criminal sanctions.</P>
<P ALIGN="JUSTIFY">In the early 1990's, the review time by the United States Food and Drug Administration ("FDA") to clear medical devices for commercial release lengthened and the number of clearances, both of 510(k) submissions and pre-market approval
applications, decreased. In response to public and congressional concern, the FDA Modernization Act of 1997 was adopted with the intent of bringing
better definition to
the clearance process. While FDA review times have improved since passage of the 1997 Act, there can be no assurance that the FDA review process will not involve delays or that clearances will be granted on a timely basis. </P>
<P ALIGN="JUSTIFY">Medical device laws are also in effect in many of the countries in which the company does business outside the United States. These range from comprehensive device approval requirements for some or all of the company's medical device
products to requests for product data or certifications. The number and scope of these requirements are increasing.</P>
<P ALIGN="JUSTIFY">Government and private sector initiatives to limit the growth of health care costs, including price regulation and competitive pricing, are continuing in many countries where the company does business, including the United States. These
changes are causing the marketplace to put increased emphasis on the delivery of more cost-effective medical therapies. Although the company
believes it is well
positioned to respond to changes resulting from this worldwide trend toward cost containment, the uncertainty as to the outcome of any proposed legislation or changes in the marketplace precludes the company from predicting the impact these changes may
have on future operating results.</P>
<P ALIGN="JUSTIFY">In keeping with the increased emphasis on cost-effectiveness in health care delivery, the current trend among hospitals and other customers of medical device manufacturers is to consolidate into larger purchasing groups to enhance
purchasing power. The medical device industry has also experienced some consolidation, partly in order to offer a broader range of products to large
purchasers. As a result,
 transactions with customers are more significant, more complex and tend to involve more long-term contracts than in the past. This enhanced purchasing power may also increase the pressure on product pricing, although management is unable to estimate the
potential impact at this time.</P>
<U><P ALIGN="JUSTIFY">Raw Materials</P>
</U><P ALIGN="JUSTIFY">The company uses a wide variety of readily available plastics, textiles, alloys and latex materials for conversion into its devices. These materials are primarily purchased from external suppliers. Certain of the raw materials are
available only from sole suppliers. Materials are purchased from single sources for reasons of quality assurance, sole source availability, cost effectiveness or
constraints resulting from regulatory requirements. Bard works closely with its suppliers to assure continuity of supply while maintaining high quality and reliability. Agreements with certain suppliers can be terminated by either party upon short notice.
The establishment of additional or replacement suppliers for certain materials cannot be accomplished quickly, largely due to the FDA approval system and the
complex nature of the manufacturing processes employed by many suppliers. In addition, in an effort to reduce potential product liability exposure, certain suppliers have terminated or are planning to terminate sales of certain materials to companies that
manufacture implantable medical devices. The Biomaterials Access Assurance Act was adopted in 1998 to help ensure availability of raw materials to the manufacturers
of medical devices. Management cannot estimate the impact of this law on supplier arrangements at this time.</P>
<P ALIGN="CENTER">I-4</P>
<U><P ALIGN="JUSTIFY">Environment</P>
</U><P ALIGN="JUSTIFY">The company is subject to various environmental laws and regulations both within and outside the United States. The operations of the company, like those of other medical device companies, involve the use of substances regulated
under environmental laws, primarily in manufacturing and sterilization processes. While the company continues to make capital and operational expenditures relating to
compliance with existing environmental laws and regulations, management believes that such compliance will not have a material impact on the company's financial position, results of operations or liquidity.</P>
<U><P ALIGN="JUSTIFY">Employees</P>
</U><P ALIGN="JUSTIFY">The company employs approximately 7,700 persons.</P>
<U><P ALIGN="JUSTIFY">Seasonality</P>
</U><P ALIGN="JUSTIFY">The company's business is not affected to any material extent by seasonal factors.</P>
<U><P ALIGN="JUSTIFY">Research and Development</P>
</U><P ALIGN="JUSTIFY">The company's research and development expenditures amounted to approximately $53,800,000 in 1999, $72,700,000 in 1998 and $85,800,000 in 1997.</P>
<U><P ALIGN="JUSTIFY">Intellectual Property</P>
</U><P ALIGN="JUSTIFY">The company owns patents on certain of its products and obtains licenses from others as it deems necessary to its business. The company's policy is to obtain patents on its products whenever practical. Technological advancement
characteristically has been rapid in the medical device industry and the company does not consider its business to be materially dependent upon any individual patent.</P>
<U><P ALIGN="JUSTIFY">Item 2.</U> <U>Properties</P>
</U><P ALIGN="JUSTIFY">The executive offices of the company are located in Murray Hill, New Jersey, in facilities that the company owns. Domestic manufacturing and development units are located in Arizona, Georgia, Kansas, Massachusetts, New Jersey, New
York, Ohio, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, Texas and Utah. Sales offices and distribution points are in these locations as well as others.</P>
<P ALIGN="JUSTIFY">Outside the U.S., the company has plants or offices in Australia, Belgium, Canada, China, France, Germany, Hong Kong, India, Italy, Korea, Malaysia, Mexico, the Netherlands, Norway, Portugal, Singapore, Spain, Sweden, Switzerland and
the United Kingdom.</P>
<P ALIGN="JUSTIFY">The company owns approximately 1,790,000 square feet in 17 locations and leases approximately 1,100,000 square feet of space in 48 locations.</P>
<P ALIGN="JUSTIFY">All these facilities are well maintained and suitable for the operations conducted in them.</P>
<P ALIGN="CENTER">I-5</P>
<U><P ALIGN="JUSTIFY">Item 3.</U> <U>Legal Proceedings</P>
</U><P ALIGN="JUSTIFY">During 1993, the United States Environmental Protection Agency (the "EPA") notified the company's Urological division that it may be a potentially responsible party relative to cleanup of the Frontier Chemical site in Niagara Falls,
New York. In September 1993, the company entered into a consent order concerning the first phase of the cleanup, which was a drum removal action. The company's
liability for the first phase was $119,000. A second phase of remedial action involves removal of waste in several large tanks. The company's liability for this phase was assessed at less than $15,000. The third phase of remedial action involves soil and
groundwater contamination. The company's responsibility, if any, for cleanup of this phase is unknown at this time, but the final resolution of this matter is not
expected to have a material adverse financial impact on the company.</P>
<P ALIGN="JUSTIFY">During 1992, the EPA notified the company that it had been identified as a potentially responsible party in connection with an ongoing investigation of the Solvents Recovery Service of New England site in Southington, Connecticut.
Although the full extent of liability in this case is unknown, the company has been identified with less than one-half percent of the total gallonage of waste materials.
Beginning in 1995, the company, together with several hundred other parties, entered into two consent orders to perform the remedial investigation and feasibility study and two removal actions with respect to groundwater contamination. The final
resolution of this matter is not expected to have a material adverse financial impact on the company.</P>
<P ALIGN="JUSTIFY">Davol Inc., a Bard subsidiary, has been identified as a Potentially Responsible Party by the Massachusetts Department of Environmental Protection for two new Superfund sites in Dartmouth and Freetown, Massachusetts. The allegations stem
from transhipments of waste from the ReSolve hazardous waste reprocessing facility in Dartmouth, Massachusetts to each of the sites associated with the H&amp;M Drum
Company. At this time, Davol Inc. and the other former ReSolve waste generators have agreed to contribute $1,000 towards a fund to finance a site investigation. The final resolution of this matter is not expected to have a material adverse financial
impact on the company.</P>
<P ALIGN="JUSTIFY">The company is subject to various legal proceedings and claims including claims of alleged personal injuries as a result of exposure to natural rubber latex gloves distributed by the company and other product liability matters,
intellectual property matters and disputes on agreements which arise in the ordinary course of business. The company believes that these legal matters will likely be disposed
 of over an extended period of time and should not have a material adverse impact on the company's consolidated financial position or results of operations.</P>
<U><P ALIGN="JUSTIFY">Item 4.</U> <U>Results of Votes of Security Holders</P>
</U><P ALIGN="JUSTIFY">Not applicable.</P>
<P ALIGN="CENTER">I-6</P>
<U><P ALIGN="JUSTIFY">Executive Officers of the Registrant</P>
</U><P ALIGN="JUSTIFY">Set forth below is the name, age, position, five-year business history and other information with respect to each executive officer of the company as of March 1, 2000. No family relationships exist among the officers of the company.
</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=629>
<TR><TD WIDTH="32%" VALIGN="TOP">
<P ALIGN="CENTER"><U><FONT FACE="Garamond">Name </U></FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">Age</U></FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">Position </U></FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP" HEIGHT=31>
<FONT FACE="Garamond"><P>William H. Longfield</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP" HEIGHT=31>
<FONT FACE="Garamond"><P ALIGN="CENTER">61</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP" HEIGHT=31>
<FONT FACE="Garamond"><P>Chairman and Chief Executive Officer and Director</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;Guy J. Jordan</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">51</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Group President</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;Timothy M. Ring</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">42</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Group President</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;John H. Weiland</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">44</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Group President</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;Charles P. Slacik</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">45</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Senior Vice President and Chief Financial Officer</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;Nadia C. Adler</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">55</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President and General Counsel and Secretary</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;James R. Adwers, M.D.</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">56</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President - Medical Affairs</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;E. Robert Ernest</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">59</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President - Planning and Development</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;Christopher D. Ganser</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">47</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President - Quality Assurance</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Hope Greenfield</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">48</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President - Human Resources</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Charles P. Grom</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">52</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President and Controller</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Richard D. Manthei</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">64</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President - Scientific Affairs</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Earle L. Parker</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">56</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President and Chief Investor Relations Officer</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Todd C. Schermerhorn</FONT></TD>
<TD WIDTH="11%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">39</FONT></TD>
<TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President and Treasurer</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">All officers of the company are elected annually by the Board of Directors.</P>
<P ALIGN="CENTER">I-7</P>
<U><P ALIGN="JUSTIFY">Executive Officers of the Registrant</U> (continued)</P>
<P ALIGN="JUSTIFY">William H. Longfield joined Bard in 1989 as executive vice president and chief operating officer. Prior to joining the company was president and chief executive officer of Cambridge Group, Inc. Previously was executive vice
president-operations of Lifemark, Inc. and, prior thereto, was employed by American Hospital Supply Corporation where he held a number of positions including president of the
Convertors division. Elected president and chief operating officer in 1991, delegated the duties and responsibilities of chairman and chief executive officer in 1993, elected president and chief executive officer in 1994 and to present position in 1995.
Elected to Board of Directors in 1990.</P>
<P ALIGN="JUSTIFY">Guy J. Jordan joined Bard in 1986 as director of research and development for USCI. Promoted to vice president for specialty access products in 1990 for Davol. In 1991 promoted to vice president and general manager of Bard Access
Systems and became president of the division in 1993. Elected to group vice president in October 1996 and to present position in April 1997. Prior to joining Bard, he
was with American Cyanamid Corporation.</P>
<P ALIGN="JUSTIFY">&nbsp;Timothy M. Ring joined Bard in 1992 as vice president-human resources. Prior to joining the company was with Abbott Laboratories, Inc. for ten years, most recently with their Hospital Products division as director of personnel.
Elected to group vice president in 1993 and to present position in 1997.</P>
<P ALIGN="JUSTIFY">John H. Weiland joined Bard in 1996 as group vice president. Prior to joining the company was senior vice president at Dentsply International. Previously served as president and chief executive officer of Pharmacia Diagnostics, Inc. and
was with American Hospital Supply and Baxter Healthcare. Served one year as a White House Fellow in the role of Special Assistant in the Office of Management and
Budget. Elected to present position in 1997.</P>
<P ALIGN="JUSTIFY">Charles P. Slacik joined Bard in 1999 as senior vice president and chief financial officer. Prior to joining the company was with American Home Products Corporation since 1983 in various financial and operating positions, the most
recent as chief operating officer for Solgar Vitamin and Herb Company. Other American Home Products positions included senior vice president of finance for Whitehall-Robins
Healthcare division and Sherwood-Davis &amp; Geck Corp.; corporate controller for American Home Products and executive vice president of Whitehall-Robins Healthcare division.</P>
<P ALIGN="JUSTIFY">Nadia C. Adler joined Bard in 1999 as vice president, general counsel and secretary. Prior to joining Bard was senior vice president, general counsel and assistant secretary of Montefiore Medical Center in New York City since 1987.
Before Montefiore, she was a partner in the law firm of Rosenman &amp; Colin as a member of the litigation department and later their corporate department. </P>
<P ALIGN="JUSTIFY">James R. Adwers, M.D. joined Bard in 1995 as regional vice president, surgical group, corporate medical affairs. Promoted to staff vice president of the corporate medical affairs group in 1996. Prior to joining the company, he held
medical affairs positions in Becton, Dickinson and Co. and Technomed International. Promoted to present position in 1997.</P>
<P ALIGN="CENTER">I-8</P>
<U><P ALIGN="JUSTIFY">Executive Officers of the Registrant</U> (continued)</P>
<P ALIGN="JUSTIFY">E. Robert Ernest joined Bard in 1977 as director of market research and business development. Prior to joining Bard he was with Abbott Laboratories for ten years. Promoted to vice president-business development in 1979 and named to
present position in 1994.</P>
<P ALIGN="JUSTIFY">Christopher D. Ganser joined Bard in 1989 as manager-quality assurance in the Moncks Corner, South Carolina facility. Promoted to division manager-quality control operations in 1991 and to director of quality assurance of Bard
Urological division in 1992. Promoted to present position in 1994. Prior to joining Bard, he held several quality assurance positions with Kendall McGaw.</P>
<P ALIGN="JUSTIFY">Hope Greenfield joined Bard in 1995 in her present position. Prior to joining the company, she was with Digital Equipment Corporation for sixteen years where she served as human resources director and vice president for various divisions.
</P>
<P ALIGN="JUSTIFY">Charles P. Grom joined Bard in 1977 as corporate accounting manager and promoted to corporate cost and budget manager in 1980. Served as division controller for various Bard divisions between 1981 and 1988 when he was promoted to
assistant corporate controller. Elected controller in 1994 and to his present position in 1995.</P>
<P ALIGN="JUSTIFY">Richard D. Manthei joined Bard in 1996 in his current position. Prior to joining the company, he was a partner in the law firm of McKenna and Cuneo in Washington, D.C., where he chaired the Food, Drug, Cosmetic, and Medical Device
Department. He previously served as managing partner at Burditt, Bowles &amp; Radzius. He held prior positions with American Hospital Supply Corporation.</P>
<P ALIGN="JUSTIFY">E. L. (Duke) Parker joined Bard in 1979 as corporate cost and budget manager. Promoted to assistant controller of Bard Urological division in 1980, to controller of USCI division in 1981 and to vice president and controller in 1985.
Promoted to vice president-operations of USCI division in 1990, to vice president and general manager of USCI Angiography division in 1991, to treasurer in 1992, to vice
president and treasurer in 1994, and to present position in 1998.</P>
<P ALIGN="JUSTIFY">Todd C. Schermerhorn joined Bard in 1985 as cost analyst and has held increasingly responsible financial positions including controller of the Vascular Systems division and vice president and controller at USCI. Most recently he was
vice president and group controller for Bard's Global Cardiology unit. He was promoted to his present position in 1998.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">I-9</P>
<P ALIGN="JUSTIFY">&#9;<U>PART II</P>
<P ALIGN="JUSTIFY">Item 5. Market for Registrant's Common Stock and Related Stockholder Matters</P>
<P ALIGN="JUSTIFY">Market and Market Prices of Common Stock</P>
</U><P ALIGN="JUSTIFY">The company's common stock is traded on the New York Stock Exchange under the symbol: BCR. The following table illustrates the high and low sales prices as traded on the New York Stock Exchange for each quarter during the last two
years.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=648>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=27>
<P></TD>
<TD WIDTH="68%" VALIGN="TOP" COLSPAN=4 HEIGHT=27>
<FONT FACE="Garamond"><P>&nbsp;</P>
<U><P ALIGN="CENTER">Quarters </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=27>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=29>
<FONT FACE="Garamond"><P>&nbsp;&nbsp;</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=29>
<U><FONT FACE="Garamond"><P>1st </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=29>
<U><FONT FACE="Garamond"><P>2nd </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=29>
<U><FONT FACE="Garamond"><P>3rd </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=29>
<U><FONT FACE="Garamond"><P>4th </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=29>
<U><FONT FACE="Garamond"><P>Year </U></FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P>1999</U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;High</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>59-7/8 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>54-3/4 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>53-11/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>58-3/8 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>59-7/8 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Low</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>45-1/4 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>41-11/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>43-15/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>46-5/8 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>41-11/16 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Close</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>50-7/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>47-13/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>47-1/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>53 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>53 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P>1998</U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>High</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>38-1/4 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>38-7/8 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>41-5/8 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>50-1/4 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>50-1/4 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Low</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>28-1/2 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>32-7/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>32-3/4 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>33-7/8 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>28-1/2 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Close</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>36-3/4 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>38-1/16 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>36-7/8 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>49-1/2 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>49-1/2 </FONT></TD>
</TR>
</TABLE>

<P ALIGN="JUSTIFY"></P>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=652>
<TR><TD WIDTH="33%" VALIGN="TOP">
<P ALIGN="CENTER"><U><FONT FACE="Garamond">&nbsp;</P>
<P ALIGN="CENTER">Title of Class</U></FONT></TD>
<TD WIDTH="67%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">Number of Record Holders of the
company's</P>
<U><P ALIGN="CENTER">Common stock as of February 29, 2000</U></FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">Common Stock - $.25 par value</FONT></TD>
<TD WIDTH="67%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">7,463</FONT></TD>
</TR>
</TABLE>

<U><FONT FACE="Garamond"><P ALIGN="JUSTIFY">Dividends</P>
</U><P ALIGN="JUSTIFY">The company paid cash dividends of $40,100,000, or $.78 per share, in 1999 and $41,500,000, or $.74 per share in 1998. The following table illustrates the quarterly rate of dividends paid per share.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=648>
<TR><TD WIDTH="17%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="68%" VALIGN="TOP" COLSPAN=4>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">Quarters </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;&nbsp;</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;<U>1st </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">2nd </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">3rd </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">4th </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">Year</U></FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P>1999</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .19</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .19</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .20</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .20</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .78</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P>1998</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .18</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .18</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .19</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .19</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">$ .74</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">In December 1999 the first quarter dividend of $.20 per share was declared, indicating an annual rate of $.80 per share. The first quarter dividend was paid on February 4, 2000 to shareholders of record on January 24
 .</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-1</P>
<U><P ALIGN="JUSTIFY">Item 6. Selected Financial Data</P>
<P ALIGN="JUSTIFY">C. R. BARD, INC. AND SUBSIDIARIES</P></U></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=654>
<TR><TD VALIGN="TOP" COLSPAN=12>
<P ALIGN="CENTER"><U><FONT FACE="Garamond" SIZE=1>For the Years Ended December 31, </U></FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=29>
<FONT FACE="Garamond" SIZE=1><P>($ in thousands except share and per share amounts)</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=29>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1999 </U></FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=29>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1998 </U></FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=29>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1997 </U></FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=29>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1996 </U></FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=29>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1995 </U></FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=29>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1994 </U></FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>INCOME STATEMENT DATA</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net sales</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,036,500</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,164,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,213,500</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,194,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,137,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,064,600</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net income</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 118,100</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 252,300</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 72,300</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 92,500</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 86,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 75,600</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>BALANCE SHEET DATA</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>&nbsp;Total assets</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,126,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,079,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,279,300</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,332,500</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,091,000</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$1,043,100</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Working capital</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 176,600</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 185,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 252,900</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 240,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 230,600</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 72,300</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Long-term debt</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 158,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 160,000</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 340,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 342,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 198,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 93,400</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Total debt</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 288,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 162,000</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 443,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 491,000</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 265,300</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 294,000</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Shareholders' investment</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 574,300</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 567,600</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 573,100</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 601,500</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 564,600</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 495,400</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>COMMON STOCK DATA</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Basic earnings per share</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 2.31</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 4.54</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.27</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.62</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.53</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.34</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Diluted earnings per share</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 2.28</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 4.51</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.26</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.61</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.52</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 1.33</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Cash dividends per share</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ .78</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ .74</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ .70</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ .66</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ .62</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ .58</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Shareholders' investment per share</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 11.31</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 11.02</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 10.09</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 10.56</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 9.89</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 8.77</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Average shares outstanding (000's)</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">51,183</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">55,566</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">56,971</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">57,090</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">56,731</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">56,461</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Shareholders of record</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7,344</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">6,650</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7,088</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7,371</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7,644</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">8,104</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>SUPPLEMENTARY DATA</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>&nbsp;Return on average shareholder investment</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">20.7%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">44.2%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">12.3%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">15.9%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">16.4%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">16.2%</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net income/net sales</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">11.4%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">21.7%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">6.0%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7.7%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7.6%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7.1%</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Days accounts receivable</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">70.8 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">72.8 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">69.6 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">70.3 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">66.7 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">62.3 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Days inventory</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">158.9 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">151.9 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">151.9 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">151.7 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">149.4 </FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">143.6 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Total debt/total capitalization</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">33.5%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">22.2%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">43.6%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">44.9%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">32.0%</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">37.2 </FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Interest expense</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 19,300</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 26,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 32,900</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 26,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 24,200</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 16,300</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Research and development expense</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 53,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 72,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 85,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 77,300</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 75,600</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 71,600</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Number of employees</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">7,700</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">9,550</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">9,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">9,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">8,900</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net sales per employee</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 134.6</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 151.3</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 127.1</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 121.9</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 121.0</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 119.6</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net income per employee</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 15.3</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 32.8</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 7.6</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 9.4</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 9.2</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 8.5</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-2</P>
<U><P ALIGN="JUSTIFY">Item 7.</U> <U>Management's Discussion and Analysis of Results of Operations and of Financial Conditions</U> </P>
<U><P>General</P>
</U><P ALIGN="JUSTIFY">For more than 90 years, C. R. Bard, Inc. has committed its resources to creating innovative solutions to meet the needs of both health care providers and their patients. The company is a global leader in the development, manufacture
and supply of products and services to the health care industry. Bard addresses the health care opportunity through disease state management - an approach
that expands the focus from products and technologies to the underlying
clinical condition, thereby positioning the company as an indispensable
partner to the deliverers of health care. Bard is committed to developing
leadership franchises within the disease states and using these strategic
positions to leverage the company's growth.</P>
<P ALIGN="JUSTIFY">After a significant divestiture and restructuring program, Bard has demonstrated improved growth and profitability trends in 1999.</P>
<U><P>Summary Results</P>
</U><P ALIGN="JUSTIFY">Bard reported 1999 net sales of $1,036.5 million, up 7% over 1998 net sales of ongoing products of $968.9 million. The company demonstrated substantial sales growth in each of its four product groups: vascular, urology, oncology and
surgery. Bard reported net income of $118.1 million or $2.28 of diluted earnings per share in 1999 compared with net income of $252.3 million or $4.51 of
diluted earnings per share in 1998. Both years' earnings include one-time
items. Without these one-time items, diluted earnings per share was $2.27
in 1999 and $1.76 in 1998, a 29% increase. Net of one-time items, Bard also
significantly increased its margin of net income to net sales to 11.3%
from 8.4% in 1998.</P>
<U><P>Results of Operations - 1999 vs. 1998</P>
</U><P ALIGN="JUSTIFY">Net sales for 1999 totaled $1,036.5 million. Bard reported net sales for 1998 of $1,164.7 million, which included sales from products which were divested during that year. On an ongoing product basis, 1999 net sales represent a 7%
increase over 1998 net sales of $968.9 million. Price reductions and the impact of a stronger dollar had the effect of reducing 1999 net sales by 1.1% and
0.4%, respectively.</P>
<P ALIGN="JUSTIFY">Sales of vascular products increased 8% in 1999 to $226.2 million. The electrophysiology and peripheral technology franchises continued to show strong worldwide growth. IMPRA graft sales also displayed healthy growth in 1999.</P>
<P ALIGN="JUSTIFY">Urology product group sales increased 4% in 1999 to $353.6 million. Basic drainage products experienced double-digit growth, fueled by outstanding sales of the Infection Control Foley catheter.</P>
<P ALIGN="JUSTIFY">Sales of oncology products increased 12% in 1999 to $238.0 million. Specialty access products demonstrated balanced growth worldwide, while interventional products showed particularly strong growth internationally.</P>
<P ALIGN="JUSTIFY">Sales of surgery products grew 11% in 1999 to $164.5 million, paced by the mesh product line, used primarily in hernia repair.</P>
<P ALIGN="JUSTIFY">The product group areas discussed above represent
substantially all of Bard's ongoing product sales.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-3</P>
<P>Net sales by product group for the last three years (in thousands) are:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=523>
<TR><TD WIDTH="32%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vascular</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 226,200 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 209,000 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 198,000 </FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Urology</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">353,600 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">339,800 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">323,400 </FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Oncology</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">238,000 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">213,100 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">199,100 </FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Surgery&#9;</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">164,500 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">148,400 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">134,800 </FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Other ongoing products</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">54,200</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">58,600</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">58,200</U> </FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Total ongoing products</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">1,036,500 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">968,900 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">913,500 </FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Divested products</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">---</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">195,800</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">300,000</U> </FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP" HEIGHT=18>
<FONT FACE="Garamond"><P>Net sales</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=18>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,036,500</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=18>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,164,700</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=18>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,213,500</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>&#9;&#9;</P>
<P ALIGN="JUSTIFY">Net sales in the U. S. of ongoing products rose 7% to $736.7 million. The oncology and surgery products provided the best growth.</P>
<P ALIGN="JUSTIFY">Net sales of ongoing products outside the U.S. also increased 7% to $299.8 million, with growth demonstrated by vascular and oncology products. For the year, a stronger dollar had the impact of reducing these sales by 1%.</P>
<P ALIGN="JUSTIFY">Bard markets its products through direct selling organizations and selected distributors throughout the world. The geographic breakdown of net sales of ongoing products for each of the last three years is proportioned as follows: United
States - 71%, Europe - 19%, Japan - 5% and Other - 5%.</P>
<P ALIGN="JUSTIFY">Despite continued pricing pressure, cost of goods sold
as a percent of net sales declined from 47.6% in 1998 to 44.6% in 1999.
These improved results are due to the company's ongoing manufacturing
restructuring programs and the divestitures of the lower-margin cardiology
businesses.</P>
<P ALIGN="JUSTIFY">Marketing, selling and administrative expense declined
13% in 1999. As a percent of sales, these expenses declined to 31.9%
from 32.6% in 1998. This reduction was attributed to the cardiology
divestitures and improved efficiency in the company's sales and
administration efforts. Reported research and development expense
declined 26%, due to the impact of the cardiology divestitures;
however, research and development spending on non-divested businesses
increased in 1999.</P>
<P ALIGN="JUSTIFY">Interest expense declined 27% in 1999 due to lower average debt levels and improved operating cash flow.</P>
<P ALIGN="JUSTIFY">Please refer to Note 9, Other (Income) Expense, Net, of the Notes to Consolidated Financial Statements on page II-24 in this report for a summary of items in this category in the last three years. Included in 1999 is a pretax charge of
$8.4 million for the writedown of impaired assets and $2.1 million of interest income.</P>
<P ALIGN="JUSTIFY">The company recorded one-time gains in both 1999 and 1998 related to the dispositions of its cardiology product lines. A pretax gain of $9.2 million was recorded in the fourth quarter of 1999 and a pretax gain of $329.2 million was
recorded in the fourth quarter of 1998. Please refer to Note 2, Acquisitions and Dispositions, of the Notes to Consolidated Financial Statements on page
II-16 for additional disclosure.</P>
<P ALIGN="JUSTIFY">The effective tax rate was 31.9% in 1999 and 45.7% in 1998. The 1998 effective tax rate includes the impact of the gain from the disposition of the cardiology businesses, which was taxed at an effective rate of approximately 50%.</P>
<P ALIGN="CENTER">II-4</P>
<U><P>Net Income</P>
</U><P ALIGN="JUSTIFY">In 1999, Bard reported net income of $118.1 million or diluted earnings per share of $2.28. Excluding the impact of the after-tax gain on the sale of the cardiopulmonary business of $0.12 and the after-tax impact of the fourth
quarter writedown of impaired assets of ($0.11), diluted earnings per share was $2.27.</P>
<P ALIGN="JUSTIFY">In 1998, Bard reported net income of $252.3 million or diluted earnings per share of $4.51. Excluding the impact of the after-tax gain on the sale of the cardiology businesses of $2.93, the net after-tax loss from one-time items of
($0.13) and the after-tax impact of the Year 2000 costs of ($0.05), diluted earnings per share was $1.76.</P>
<P ALIGN="JUSTIFY">In 1997, Bard reported net income of $72.3 million or diluted earnings per share of $1.26. Excluding the net after-tax loss from one-time items of ($0.38) and the after-tax impact of the Year 2000 costs of ($0.03), diluted earnings per
share was $1.67.</P>
<U><P>Results of Operations - 1998 vs. 1997</P>
</U><P ALIGN="JUSTIFY">Net sales for 1998 totaled $1,164.7 million, which represents a 4% decline from the prior year mostly due to the 1998 divestiture of the cardiology businesses. Full year net sales of ongoing products were $968.9 million, an increase
of 6% over comparable 1997 results. Price reductions and the impact of a stronger dollar had the effect of reducing 1998 reported net sales by 2%
and 1%, respectively.</P>
<P ALIGN="JUSTIFY">Sales of vascular products rose 6% in 1998. Peripheral technology and electrophysiology devices showed strong worldwide growth.</P>
<P ALIGN="JUSTIFY">Urology product sales grew 5% in 1998. The Infection Control Foley catheter and the brachytherapy business provided the majority of the growth in this area.</P>
<P ALIGN="JUSTIFY">Sales of oncology products increased 7% in 1998. Specialty access devices showed good growth particularly in international markets.</P>
<P ALIGN="JUSTIFY">Sales of surgery products grew 10% in 1998, propelled by high worldwide growth of mesh products, used primarily for hernia repair.</P>
<P ALIGN="JUSTIFY">Net sales in the U.S. of ongoing products rose 5% to $687.9 million. The vascular and surgery products provided the best growth.</P>
<P ALIGN="JUSTIFY">Net sales of ongoing products outside the U.S. increased 8% to $281.0 million with growth demonstrated by urology, oncology and surgery products.</P>
<P ALIGN="JUSTIFY">Global pricing pressures together with the additional
expenditures related to Bard's ongoing manufacturing restructuring effort
increased cost of goods sold as a percent of net sales to 47.6% in 1998
from 47.2% in 1997.</P>
<P ALIGN="JUSTIFY">Marketing, selling and administrative expense
declined 3% in 1998. As a percent of net sales, these expenses increased
due to the effect of several one-time items such as Year 2000 functionality
expenditures. Reported research and development expense declined 15% in
1998 as a result of the sale of the cardiology businesses, while Bard's
spending on its ongoing products was consistent with the prior year.</P>
<P ALIGN="CENTER">II-5</P>
<P ALIGN="JUSTIFY">Interest expense declined 20% in 1998 due primarily to
Bard's decision to utilize a portion of the proceeds from the sale of the
cardiology businesses to repay short-term debt.</P>
<P ALIGN="JUSTIFY">Other (income) expense, net, in 1998 included a net gain of $48.6 million from the settlement of various patent infringement and legal claims, a charge of $34.1 million for the writedown of assets primarily associated with divested
businesses and a charge of $6.4 million related to acquired research and development.</P>
<P ALIGN="JUSTIFY">In 1998, the company divested several cardiology product lines. These transactions closed in the fourth quarter of 1998 and the company recorded a pretax gain of $329.2 million.</P>
<P ALIGN="JUSTIFY">The effective tax rate was 45.7% in 1998 and 31.1% in 1997. The increase in 1998 was largely the result of the sale of the cardiology businesses.</P>
<U><P>Net Income</P>
</U><P ALIGN="JUSTIFY">In 1998, net income increased to $252.3 million including a gain on the sale of the cardiology businesses and other one-time items as described earlier in this review.</P>
<U><P>Year 2000 Functionality</P>
</U><P ALIGN="JUSTIFY">Bard did not experience any significant internal business disruptions as a result of the calendar change to the Year 2000 functionality. To date Bard has not observed any significant disruptions at either its major customers or
vendors.</P>
<P ALIGN="JUSTIFY">The company has reviewed fourth quarter 1999 sales activity and believes that there was no significant customer stocking activity related to Year 2000 preparations. The company does not believe that it will experience significant return
activity or lower 2000 sales as a result of Year 2000 activities.</P>
<P ALIGN="JUSTIFY">The company's marketing, selling and administrative
expense included $3.3 million for IT-related Year 2000 expenditures in
1999, $4.7 million in 1998 and $2.8 million in 1997. The company
anticipates that it will spend approximately $800,000 in 2000 for final
system tests and retrofitting. These incremental costs do not include
existing internal resources allocated to Year 2000 project efforts.</P>
<U><P>Financial Condition and Liquidity</P>
</U><P ALIGN="JUSTIFY">Bard's financial condition remains strong. Total
debt was $288.7 million at December 31, 1999, up from $162.0 million at
December 31, 1998. This increase was primarily the result of acquisitions
of products and technologies, repurchases of common stock and additions to
cash at year-end to address the risk of Year 2000-related liquidity
constraints. Total debt to total capitalization was 33.5% at December 31,
1999, compared to 22.2% at December 31, 1998, while net debt, or debt less
cash and short-term investments to total capitalization was 25.1% at
December 31, 1999, compared to 17.4% at December 31, 1998. Shareholders'
investment was impacted in 1999 by the repurchase of $82.7 million of
common stock.</P>
<P ALIGN="JUSTIFY">The company has a $300 million syndicated, committed credit facility with a group of 12 banks. The company made no borrowings under this credit facility in 1999. The facility expires May 31, 2000. This facility supports a commercial
paper program of $300 million. The company borrows actively under this program.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-6</P>
<P ALIGN="JUSTIFY">In addition to the $300 million committed credit facility, Bard maintains uncommitted credit lines with banks for short-term cash needs and these lines were used as needed during the last three years. At December 31, 1999, the unused
uncommitted lines of credit totaled $131.5 million.</P>
<P ALIGN="JUSTIFY">Cash provided from operations continued to be the
company's primary source of funds to finance operating needs, capital
expenditures and dividend payments. The company believes it could borrow
adequate funds at competitive terms and rates, should it be necessary. This
overall financial strength gives Bard sufficient financing flexibility.</P>
<P ALIGN="JUSTIFY">Total cash outlays made for the purchase of businesses, patents, trademarks, purchase rights, and other related items were approximately $48 million in 1999, $50 million in 1998, and $23 million in 1997. The majority of these
investments were for intangible assets, reflecting the premium over book value for these purchases. The majority of the cash outlays were financed with additional debt, with the balance coming from cash from operations.</P>
<P ALIGN="JUSTIFY">Periodically, the company purchases its common stock in the open market to replace shares issued under various employee stock plans. In connection with the announced sale of the cardiology businesses, the Board of Directors in July of
1998 authorized the purchase from time to time of up to 10 million shares of common stock. Total shares purchased were 1,629,600 in 1999; 6,295,200 in 1998; and 955,200 in 1997.</P>
<U><P>Foreign Currency Risk</P>
</U><P ALIGN="JUSTIFY">The company periodically enters into foreign exchange
contracts and options to reduce its exposure to fluctuations in currency
values. Contracts have been exclusively for the forward purchase of, and
options in, currencies in which the company has known or anticipated
payments. Monetary assets of the company held in foreign currencies have
relatively short maturities and are denominated in currencies that have not
experienced wide short-term fluctuations in their equivalent U.S. dollar
values.  Please refer to Note 4, Short-Term Borrowings and Long-Term Debt,
of the Notes to Consolidated Financial Statements on page II-18 of this report
for current details of the company's foreign exchange contracts.</P>
<P ALIGN="JUSTIFY">On January 1, 1999, the eleven member countries of the European Union began the transition to a common currency, the "Euro." These participating countries expect the Euro transition to be completed by July 2002.</P>
<P ALIGN="JUSTIFY">The company is currently evaluating potential Euro-related issues including: pricing/marketing strategy, conversion of computer systems, existing contracts and currency risk in the participating countries. At the present time,
management does not believe the Euro conversion will have a materially adverse impact on our business.</P>
<U><P ALIGN="JUSTIFY">Legal Proceedings</P>
</U><P ALIGN="JUSTIFY">For a discussion of pending legal proceedings and related matters, please see Note 5, Commitments and Contingencies, of the Notes to Consolidated Financial Statements on page II-19.</P>
<U><P>Acquisitions and Dispositions</P>
</U><P ALIGN="JUSTIFY">For information on the company's acquisitions and
dispositions of businesses, please see Note 2, Acquisitions and
Dispositions, of the Notes to Consolidated Financial Statements on page
II-16.</P>
<P ALIGN="CENTER">II-7</P>
<U><P>Cautionary Statement Regarding Forward-Looking Information</P>
</U><P ALIGN="JUSTIFY">Certain statements contained herein or in other
company documents and certain statements that may be made by management of
the company orally, including statements regarding the use of net proceeds
from the sale of the company's cardiology businesses, statements regarding
cost savings from restructuring and statements regarding the company's
future performance, may contain forward-looking statements as defined in
the Private Securities Litigation Reform Act of 1995. Because actual
results are affected by risks and uncertainties, the company cautions
investors that actual results may differ materially from those expressed
or implied. Factors that could cause the actual results to differ materially
from expected and historical results include, but are not limited to:
health care industry consolidation resulting in customer demands for price
concessions and contracts that are more complex and have longer terms;
competitive factors, including competitors' attempts to gain market share
through aggressive marketing programs, the development of new products or
technologies by competitors and technological obsolescence; reduction
in medical procedures performed in a cost-conscious environment; the
lengthy approval time by the FDA or other government authorities to clear
medical devices for commercial release; unanticipated product failures;
legislative or administrative reforms to the U.S. Medicare and Medicaid
systems or other non-U.S. reimbursement systems in a manner that would
significantly reduce reimbursements for procedures using the company's
medical devices; the acquisition of key patents by competitors that would
have the effect of excluding the company from new market segments; the
uncertainty of whether increased research and development expenditures will
result in increased sales; unpredictability of existing and future
litigation including litigation regarding product liability and intellectual
property; government actions or investigations affecting the industry in
general or the company in particular; future difficulties obtaining
product liability insurance on reasonable terms; efficacy or safety
concerns with respect to marketed products, whether scientifically
justified or not, that may lead to product recalls, withdrawals or
declining sales; uncertainty related to tax appeals and litigation; future
difficulties obtaining necessary components used in the company's products
and/or price increases from the company's suppliers of critical components;
economic factors over which the company has no control, including changes
in inflation, foreign currency exchange rates and interest rates; other
factors over which the company has no control, including earthquakes,
floods, fires and explosions; risks associated with maintaining and
expanding international operations; and the risk that the company may not
achieve manufacturing or administrative efficiencies as a result of the
company's restructuring, the integration of acquired businesses or
divestitures.</P>
<U><P ALIGN="JUSTIFY">&nbsp;</P>
</U><P ALIGN="CENTER">II-8</P>
<U><P ALIGN="JUSTIFY">Item 8.</U> <U>Financial Statements and Supplementary Data</P>
<P ALIGN="JUSTIFY">Report of Independent Public Accountants</P>
</U><P ALIGN="JUSTIFY">We have audited the accompanying consolidated balance sheets of C. R. Bard, Inc. (a New Jersey corporation) and subsidiaries as of December 31, 1999 and 1998, and the related consolidated statements of income, shareholders'
investment and cash flows for each of the three years in the period ended December 31, 1999. These financial statements are the
responsibility of the company's management. Our responsibility is to express an opinion on these financial statements based on our audits.</P>
<P ALIGN="JUSTIFY">We conducted our audits in accordance with generally accepted auditing standards. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material
misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our
opinion.</P>
<P ALIGN="JUSTIFY">In our opinion, the financial statements referred to above present fairly, in all material respects, the financial position of C. R. Bard, Inc. and subsidiaries as of December 31, 1999 and 1998, and the results of their operations and
their cash flows for each of the three years in the period ended December 31, 1999 in conformity with generally accepted
accounting principles.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">ARTHUR ANDERSEN LLP</P>
<P ALIGN="JUSTIFY">Roseland, New Jersey</P>
<P ALIGN="JUSTIFY">January 26, 2000</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-9</P>
<B><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">CONSOLIDATED STATEMENTS OF INCOME</P>
<P ALIGN="CENTER">(thousands of dollars except per share amounts)</P></B></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=586>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<P><FONT FACE="Garamond">&nbsp;</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="51%" VALIGN="TOP" COLSPAN=5 HEIGHT=28>
<B><U><FONT FACE="Garamond"><P ALIGN="RIGHT">For the Years Ended</P>
<P ALIGN="RIGHT">December 31,</B></U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;<B><U>1999 </B></U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<B><U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </B></U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<B><U><FONT FACE="Garamond"><P ALIGN="RIGHT">1997 </B></U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Net sales</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,036,500 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,164,700 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,213,500</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Costs and expenses:</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28><P></P></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28><P></P></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>&nbsp;Cost of goods sold</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">462,300 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">554,100 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">572,800</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Marketing, selling and administrative</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">330,500 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">379,200 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">390,500</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Research and development</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">53,800 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">72,700 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">85,800</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Interest expense</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">19,300 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">26,400 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">32,900</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Gain from dispositions of cardiology businesses</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(9,200)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(329,200)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">---</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Other (income) expense, net</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">6,500</U> </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(2,900</U>)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">26,600</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Total costs and expenses</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">863,200</U> </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">700,300</U> </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1,108,600</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Income before taxes</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">173,300 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">464,400 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<FONT FACE="Garamond"><P ALIGN="RIGHT">104,900</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Income tax provision</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">55,200</U> </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">212,100</U> </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">32,600</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Net income</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 118,100 </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 252,300 </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 72,300</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Basic earnings per share</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 2.31 </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 4.54 </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 1.27</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=28>
<FONT FACE="Garamond"><P>Diluted earnings per share</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 2.28 </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 4.51 </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" COLSPAN=2 HEIGHT=28>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 1.26</U></FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">The accompanying notes to consolidated financial statements are an integral part of these statements.</P>
<P ALIGN="CENTER">II-10</P>
<B><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">CONSOLIDATED STATEMENTS OF SHAREHOLDERS' INVESTMENT</P>
<P ALIGN="CENTER">(thousands of dollars except share and per share amounts)</P></B></FONT>
<P ALIGN="CENTER"><CENTER><TABLE CELLSPACING=0 BORDER=0 CELLPADDING=6 WIDTH=589>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P>&nbsp;</B></FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Common Stock Shares</B></FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Common Stock   Amount</B></FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">Capital in Excess of Par Value</B></FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Retained Earnings</B></FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Cum. Trans. Adjust.</B></FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Unearned Comp.</B></FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<B><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Total</B></FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P>Balance at December 31, 1996</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">56,985,983 </FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 14,300 </FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 77,500</FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$506,700 </FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ 8,000 </FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$ (5,000)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=30>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$601,500 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net income</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">72,300 </FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">72,300 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Currency translation adjustments</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(46,500)</FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(46,500)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Comprehensive income</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">25,800 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Cash dividends ($.70 per share)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(40,000)</FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(40,000)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Treasury stock retired</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(955,200)</FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(300)</FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(32,300)</FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(32,600)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Employee stock plans</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">753,768 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">100</U> </FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">23,600</U></FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(5,300</U>)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">18,400</U> </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Balance at December 31, 1997</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">56,784,551 </FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">14,100 </FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">101,100</FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">506,700 </FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(38,500)</FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(10,300)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">573,100 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net income</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">252,300 </FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">252,300 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Currency translation adjustments</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">15,400 </FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">15,400 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Comprehensive income</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">267,700 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Cash dividends ($.74 per share)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">&nbsp;(41,500)</FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(41,500)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Treasury stock retired</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(6,295,200)</FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(1,400)</FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(262,700)</FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(264,100)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Employee stock plans</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">1,008,213</U> </FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">200</U> </FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">31,200</U></FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(1,200</U>)</FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">2,200</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">32,400</U> </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Balance at December 31, 1998</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">51,497,564 </FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">12,900 </FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">132,300</FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">453,600 </FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(23,100)</FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(8,100)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">567,600 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Net income</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">118,100 </FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">118,100 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Currency translation adjustments</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(25,500)</FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(25,500)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Comprehensive income</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24><P></P></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">&nbsp;92,600 </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Cash dividends ($.78 per share)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">&nbsp;</FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(40,100)</FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(40,100)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Treasury stock retired</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(1,629,600)</FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(400)</FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(82,300)</FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(82,700)</FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Employee stock plans</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">913,893</U> </FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">200</U> </FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">21,200</U> </FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">24,200</U> </FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24><P></P></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">(8,700</U>)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">36,900</U> </FONT></TD>
</TR>
<TR><TD WIDTH="14%" VALIGN="BOTTOM" HEIGHT=33>
<FONT FACE="Garamond" SIZE=1><P>Balance at December 31, 1999</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=33>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">50,781,857 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="BOTTOM" COLSPAN=3 HEIGHT=33>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$12,700 </U></FONT></TD>
<TD WIDTH="11%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=33>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$153,500 </U></FONT></TD>
<TD WIDTH="8%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=33>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$473,500 </U></FONT></TD>
<TD WIDTH="9%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=33>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$(48,600</U>)</FONT></TD>
<TD WIDTH="15%" VALIGN="BOTTOM" COLSPAN=2 HEIGHT=33>
<FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$<U>(16,800</U>)</FONT></TD>
<TD WIDTH="12%" VALIGN="BOTTOM" HEIGHT=33>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="RIGHT">$574,300</U> </FONT></TD>
</TR>
</TABLE>
</CENTER></P>

<FONT FACE="Garamond"><P ALIGN="CENTER">The accompanying notes to consolidated financial statements are an integral part of these statements.</P>
</FONT><FONT FACE="Courier"><P ALIGN="CENTER">II-11</P>
</FONT><B><FONT FACE="Garamond"><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">CONSOLIDATED BALANCE SHEETS</P>
<P ALIGN="CENTER">(thousands of dollars except share and par amounts)</P></B></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=504>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<P><B><FONT FACE="Garamond" SIZE=1>ASSETS</B></FONT></TD>
<TD WIDTH="51%" VALIGN="TOP" COLSPAN=6 HEIGHT=23>
<B><U><FONT FACE="Garamond"><P ALIGN="RIGHT">December 31, </B></U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=22>
<FONT FACE="Garamond"><P>Current assets:</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=22>
<B><U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </B></U></FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=22>
<B><U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </B></U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Cash </FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 17,300 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 25,600</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Short-term investments</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">78,600 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">16,800</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Accounts receivable, less reserve of $8,500 and $9,300</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">212,900 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">217,800</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Inventories</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">204,000 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">182,500</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other current assets</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">16,300</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">45,800</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total current assets</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">529,100</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">488,500</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Property, plant and equipment, at cost</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>&nbsp;Land</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">10,800 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">11,000</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Buildings and improvements</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">122,000 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">121,900</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Machinery and equipment</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">159,800</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">156,700</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;292,600 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">289,600</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Less - accumulated depreciation and amortization</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">122,900</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">116,900</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net property, plant and equipment</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">169,700</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">172,700</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Intangible assets, net of amortization</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">337,000</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">358,900</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other assets</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">90,600</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">59,700</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;<U>$1,126,400</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,079,800</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<B><FONT FACE="Garamond"><P>LIABILITIES AND SHAREHOLDERS' INVESTMENT</B></FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23><P></P></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>&nbsp;Current liabilities:</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23><P></P></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>&nbsp;Short-term borrowings and current maturities of long-term debt</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 130,300 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 2,000</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Accounts payable</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">54,300 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">67,400</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Accrued compensation and benefits</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">39,300 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">41,800</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond"><P>Accrued expenses</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">96,500 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=23>
<FONT FACE="Garamond"><P ALIGN="RIGHT">145,600</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Federal and foreign income taxes</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">32,100</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">46,000</U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total current liabilities</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">352,500</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">302,800</U> </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Long-term debt</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">158,400</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">160,000</U> </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other long-term liabilities</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">41,200</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">49,400</U> </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Commitments and contingencies</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Shareholders' investment:</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Preferred stock, $1 par value, authorized 5,000,000 shares; none issued </FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Common stock, $.25 par value, authorized 300,000,000 shares; issued and outstanding 50,781,857 shares in 1999, 51,497,564 shares in 1998</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;12,700 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">12,900 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Capital in excess of par value</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">153,500 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">132,300 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Retained earnings</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">473,500 </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">453,600 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Accumulated other comprehensive income</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(48,600)</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(23,100)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Unearned compensation</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(16,800</U>)</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(8,100</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total shareholders' investment</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">574,300</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">567,600</U> </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="26%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;<U>$1,126,400</U> </FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,079,800</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="CENTER">The accompanying notes to consolidated financial statements are an integral part of these statements.</P>
<P ALIGN="CENTER">II-12</P>
<B><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">CONSOLIDATED STATEMENTS OF CASH FLOWS</P>
<P ALIGN="CENTER">(thousands of dollars)</P></B></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=538>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<P></TD>
<TD WIDTH="51%" VALIGN="TOP" COLSPAN=7 HEIGHT=24>
<B><U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">For the Years Ended December 31,</B></U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<B><U><FONT FACE="Garamond"><P ALIGN="CENTER">1999 </B></U></FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<B><U><FONT FACE="Garamond"><P ALIGN="CENTER">1998 </B></U></FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<B><U><FONT FACE="Garamond"><P ALIGN="CENTER">1997 </B></U></FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<B><U><FONT FACE="Garamond"><P>Cash flows from operating activities:</B></U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net income</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$118,100 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$252,300 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 72,300 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Adjustments to reconcile net income to net cash provided from operating activities</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Depreciation and amortization</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">49,100 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">58,700 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">57,300 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net gain on sales of product lines, net of tax</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(6,000)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(149,200)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(13,600)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Deferred income taxes</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">16,300 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(26,300)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(15,900)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Expenses under stock plans</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">6,000 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">3,600 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">2,800 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other noncash items</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">11,200 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">31,400 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">38,200 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Changes in assets and liabilities net of acquired businesses:</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Accounts receivable</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(3,600)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">9,200 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(7,000)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Inventories</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(28,700)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(12,200)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(16,100)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other assets</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">23,300 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">17,500 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(18,300)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Current liabilities, excluding debt</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(86,300)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">27,200 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(4,400)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other long-term liabilities</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(8,900</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(4,000</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">3,200</U> </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net cash provided by operating activities</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">90,500</U> </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">208,200</U> </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">98,500</U> </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<B><U><FONT FACE="Garamond"><P>Cash flows from investing activities:</B></U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Capital expenditures</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(26,100)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(43,800)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(32,800)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net proceeds from sales of product lines</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">9,000 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">449,300 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">29,700 </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Payments made for purchases of businesses</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(17,500)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(7,200)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Patents, trademarks and other</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(47,700</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(32,000</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(15,300</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net cash provided by (used in) investing activities</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(64,800</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">356,000</U> </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(25,600</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<B><U><FONT FACE="Garamond"><P>Cash flows from financing activities:</B></U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Common stock issued for options and benefit plans</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">22,500 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">28,800 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">15,600</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Purchase of common stock</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(82,700)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(264,100)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(32,600)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Proceeds from long-term borrowings, net of issuance costs</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">5,600</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Principal payments of long-term borrowings</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(1,000)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(180,800)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(1,000)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Proceeds from (repayments of) short-term borrowings, net</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">128,500 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(101,000)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(44,900)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Dividends paid</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(40,100</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(41,500</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(40,000</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net cash provided by (used in) financing activities</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">27,200</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(558,600)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(97,300)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Translation adjustment</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(1,400</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(800</U>)</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(2,800</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Cash and cash equivalents:</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24><P></P></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Increase (decrease) during the year</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">51,500</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">4,800 </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(27,200)</FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Balance at January 1</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">41,200</U></FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">36,400</U> </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">63,600</U> </FONT></TD>
</TR>
<TR><TD WIDTH="49%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Balance at December 31</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 92,700</U> </FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 41,200</U></FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" COLSPAN=3 HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 36,400</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">The accompanying notes to consolidated financial statements are an integral part of these statements.</P>
<P ALIGN="CENTER">II-13</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">C. R. Bard, Inc. (the "company</FONT><FONT FACE="WP TypographicSymbols">@</FONT><FONT FACE="Garamond"> or </FONT><FONT FACE="WP TypographicSymbols">A</FONT><FONT FACE="Garamond">Bard</FONT><FONT FACE="WP TypographicSymbols">@</FONT>
<FONT FACE="Garamond">) is a leading multinational developer, manufacturer and marketer of health care products.
The company markets its products worldwide to hospitals, individual health care professionals, extended care facilities and alternate site facilities. Bard holds strong positions in products used for vascular, urological and oncological diagnosis and
intervention. Bard also has a surgical products group.</P>
<P ALIGN="JUSTIFY">1. Significant Accounting Policies</P>
<U><P ALIGN="JUSTIFY">Consolidation</U> The consolidated financial statements include the accounts of the company and its majority-owned subsidiaries. All significant intercompany accounts and transactions are eliminated in consolidation.</P>
<U><P ALIGN="JUSTIFY">Earnings Per Share</U> </FONT><FONT FACE="WP TypographicSymbols">A</FONT><FONT FACE="Garamond">Basic earnings per share</FONT><FONT FACE="WP TypographicSymbols">@</FONT><FONT FACE="Garamond"> represents net income divided by the
weighted average shares outstanding. </FONT><FONT FACE="WP TypographicSymbols">A</FONT><FONT FACE="Garamond">Diluted
 earnings per share</FONT><FONT FACE="WP TypographicSymbols">@</FONT><FONT FACE="Garamond"> represents net income divided by weighted average shares outstanding adjusted for the incremental dilution of outstanding employee stock options and awards. Unless
indicated otherwise, per share amounts are calculated on a diluted basis.</P>
<P ALIGN="JUSTIFY">A reconciliation of weighted average common shares outstanding to weighted average common shares outstanding assuming dilution follows:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=519>
<TR><TD WIDTH="45%" VALIGN="TOP">
<P><FONT SIZE=4>&nbsp;</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="CENTER">1999 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="CENTER">1998 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="CENTER">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P>Average common shares outstanding</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">51,183,473 </FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">55,566,453</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">56,970,849</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P>Incremental common shares issuable: Stock options and awards</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">698,436</U> </FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">&nbsp;<U>403,620</U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">302,151</U></FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P>Average common shares outstanding assuming dilution</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">51,881,909</U> </FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">55,970,073</U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">57,273,000</U></FONT></TD>
</TR>
</TABLE>

<U><FONT FACE="Garamond"><P ALIGN="JUSTIFY">Derivative Instruments</U> In June 1998, the Financial Accounting Standards Board issued Statement of Financial Accounting Standards No. 133, "Accounting for Derivative Instruments and Hedging Activities" ("FAS
133"). FAS 133 establishes accounting and reporting standards requiring that every derivative
instrument be recorded in the balance sheet as either an asset or liability measured at its fair value. FAS 133 requires that changes in the derivative's fair value be recognized currently in earnings unless specific hedge accounting criteria are met. FAS
133 is effective for fiscal years beginning after June 15, 1999 with early adoption permitted.
The adoption of FAS 133 would not have had a material impact on Bard's 1999 financial statements.</P>
<P ALIGN="CENTER">II-14</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">1. Significant Accounting Policies (continued)</P>
<U><P ALIGN="JUSTIFY">Inventories</U> Inventories are stated at the lower of cost or market. Substantially all domestic inventories are accounted for using the LIFO method of determining costs. All other inventories are accounted for using the FIFO
method. Inventories valued under the LIFO method were $138,500,000 in 1999, $123,600,000 in 1998 and
$136,800,000 in 1997; under the FIFO method such inventories would have been higher by $8,500,000, $10,900,000 and $14,500,000, respectively. The following is a summary of inventories at December 31:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=451>
<TR><TD WIDTH="52%" VALIGN="TOP">
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Finished goods</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$105,600 </FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 97,800</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Work in process</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">66,900 </FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">52,600</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Raw materials</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">31,500</U> </FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">32,100</U></FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Total</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$204,000</U> </FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$182,500</U></FONT></TD>
</TR>
</TABLE>

<U><FONT FACE="Garamond"><P ALIGN="JUSTIFY">Depreciation</U> Property, plant and equipment are depreciated on a straight-line basis over the useful lives (ranging from 3-40 years) of the various classes of assets.</P>
<U><P ALIGN="JUSTIFY">Short-term Investments</U> Short-term investments that have a maturity of ninety days or less are considered cash equivalents and amounted to $75,400,000 and $15,600,000 as of December 31, 1999 and 1998, respectively. Short-term
investments are stated at cost, which approximates their market value.</P>
<U><P ALIGN="JUSTIFY">Intangible Assets</U> Goodwill is amortized using the straight-line method over periods of 15-40 years as appropriate. Other intangible assets are amortized primarily over periods of 2-15 years, as appropriate. The company evaluates
its intangibles to assess recoverability from future operations using undiscounted cash flows.
Impairment would be recognized in operating results if a permanent diminution in value occurred.</P>
<P ALIGN="JUSTIFY">Please refer to Note 9 Other (Income) Expense, Net, for a discussion of the 1999 asset impairment charge.</P>
<P ALIGN="JUSTIFY">As of December 31, 1999 and 1998, intangible assets include the following:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=475>
<TR><TD WIDTH="45%" VALIGN="TOP">
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="28%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Goodwill</FONT></TD>
<TD WIDTH="28%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 350,300 </FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 355,900 </FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Other intangibles (primarily patents)</FONT></TD>
<TD WIDTH="28%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">180,500 </FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">167,100 </FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Less accumulated amortization</FONT></TD>
<TD WIDTH="28%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(193,800</U>)</FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(164,100</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Intangible assets, net</FONT></TD>
<TD WIDTH="28%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 337,000</U> </FONT></TD>
<TD WIDTH="26%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 358,900</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="CENTER">II-15</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">1. Significant Accounting Policies (continued)</P>
<U><P ALIGN="JUSTIFY">Federal Income Taxes</U> The company has not provided for federal income taxes on the undistributed earnings of its foreign operations as it is the company's intention to permanently reinvest undistributed earnings (approximately
$559,000,000 as of December 31, 1999).</P>
<U><P ALIGN="JUSTIFY">Concentrations of Credit Risk</U> Financial instruments, which potentially subject the company to significant concentrations of credit risk, consist principally of cash investments and trade accounts receivable.</P>
<P ALIGN="JUSTIFY">The company maintains cash and cash equivalents, investments, and certain other financial instruments with various major financial institutions. The company performs periodic evaluations of the relative credit standing of these
financial institutions and limits the amount of credit exposure with any institution.</P>
<P ALIGN="JUSTIFY">Concentrations of credit risk with respect to trade accounts receivable are limited due to the large number of customers and their dispersion across many geographic areas. However, a significant amount of trade receivables are with
national health care systems in several countries. Although the company does not currently foresee a
credit risk associated with these receivables, repayment is dependent upon the financial stability of those countries</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond"> national economies.</P>
<U><P ALIGN="JUSTIFY">Use of Estimates</U> The financial statements and related disclosures have been prepared in conformity with generally accepted accounting principles and, accordingly, include amounts based on estimates and judgments of management.
Actual results could differ from those estimates.</P>
<U><P ALIGN="JUSTIFY">Reclassifications</U> Certain prior year amounts have been reclassified to conform with the current year presentation.</P>
<P ALIGN="JUSTIFY">2. Acquisitions and Dispositions</P>
<P ALIGN="JUSTIFY">In 1999 the company completed the sale of its cardiopulmonary business. This disposition, which resulted in a pretax gain of $9,200,000 ($.12 per share after tax), was part of a series of strategic dispositions of cardiology businesses
announced in 1998. The company expects to settle in 2000 all remaining issues related to the 1998
sale of the Cath Lab Business, which is not expected to have an adverse effect on the company.</P>
<P ALIGN="JUSTIFY">Also in 1999, the company entered into an exclusive agreement with Endologix, Inc., a California-based company that has developed an endoluminal graft (ELG) used for the minimally invasive treatment of abdominal aortic aneurysms. The
agreement gives Bard exclusive distribution rights to Endologix ELG in Europe and Australia and an
exclusive and irrevocable option to acquire all of the capital stock of Endologix, Inc. before the end of 2000 at a preset price.</P>
<P ALIGN="JUSTIFY">In 1998 the company reported a pretax gain of $329,200,000 ($3.03 per share after tax) on the disposition of its cardiology businesses and a pretax loss of $17,500,000 ($.18 per share after tax) on the sale of several other product
lines (including the loss on the sale of the Diagnostic Sciences Division).</P>
<P ALIGN="CENTER">II-16</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
<OL START=2>

</U><P ALIGN="JUSTIFY"><LI>Acquisitions and Dispositions (continued)</LI></P></OL>

<P ALIGN="JUSTIFY">The 1997 financial results included the sale of two product lines that resulted in a pretax gain of $22,700,000 ($.23 per share after tax).</P>
<P ALIGN="JUSTIFY">3. Income Tax Expense</P>
<P ALIGN="JUSTIFY">Income tax expense consists of the following:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=513>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">1999 </U></FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">1998 </U></FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="CENTER">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Currently payable:</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Federal</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 22,200 </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$205,200 </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 36,300 </FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Foreign</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">11,300 </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">10,700 </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">6,600 </FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>State</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">5,400</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">22,500</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">5,600</U> </FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">38,900</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">238,400</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">48,500</U> </FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Deferred:</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;Federal</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">16,400 </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(29,800)</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(15,200)</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Foreign</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(600)</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">2,800 </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">1,000 </FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>State</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">500</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">700</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(1,700</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">16,300</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(26,300</U>)</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(15,900</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total&#9;</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 55,200</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$212,100</U> </FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 32,600</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">Deferred income taxes are recognized for the tax consequences of "temporary differences" by applying enacted statutory tax rates, applicable to future years, to differences between the financial reporting and the
tax basis of assets and liabilities. At December 31, 1999, the company's net deferred tax assets
amounted to approximately $33,800,000, which are recorded in other current assets and other assets. This amount principally comprises the tax effects of the differences between tax and financial accounting treatment of employee benefits of $10,500,000,
accrued expenses and other temporary differences of $29,800,000, offset by the effect of accelerated
depreciation of $6,500,000.</P>
<P ALIGN="JUSTIFY">The following is a reconciliation between the effective tax rates and the statutory rates, excluding the impact of the gain from the disposition of the cardiology businesses in 1998 which was taxed at approximately a 50% rate:</P></FONT>

<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=434>
<TR><TD WIDTH="46%" VALIGN="TOP" HEIGHT=24>
<P></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="15%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="46%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>U.S. federal statutory rate</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">35% </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">35% </FONT></TD>
<TD WIDTH="15%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">35% </FONT></TD>
</TR>
<TR><TD WIDTH="46%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>State income taxes net of federal income tax benefits</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3 </FONT></TD>
<TD WIDTH="15%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3 </FONT></TD>
</TR>
<TR><TD WIDTH="46%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Operations taxed at less than the U.S. statutory rate</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(8) </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(8) </FONT></TD>
<TD WIDTH="15%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(10) </FONT></TD>
</TR>
<TR><TD WIDTH="46%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Other, net</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">2 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">5 </U></FONT></TD>
<TD WIDTH="15%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3 </U></FONT></TD>
</TR>
<TR><TD WIDTH="46%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Effective tax rate</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">32%</U> </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">35%</U> </FONT></TD>
<TD WIDTH="15%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">31%</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">Cash payments for income taxes were $52,500,000, $183,100,000 and $29,400,000 in 1999, 1998 and 1997, respectively.</P>
<P ALIGN="CENTER">II-17</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">4. Short-Term Borrowings and Long-Term Debt</P>
<P ALIGN="JUSTIFY">The company maintains uncommitted lines of credit, a commercial paper program and a committed credit facility that supports the company's commercial paper program. The committed facility can also be used for other corporate purposes.
Total short-term borrowings amounted to $129,400,000 and $900,000 at December 31, 1999 and 1998,
respectively. The maximum amount of short-term borrowings outstanding during 1999 was approximately $129,400,000 with an average outstanding balance of $90,200,000 and an effective interest rate of 5.47%.</P>
<P ALIGN="JUSTIFY">At December 31, 1999, the company had short-term uncommitted borrowings of $9,900,000 and available unused lines under its uncommitted lines of credit of $131,500,000. $119,500,000 in commercial paper was outstanding at December 31,
1999. The company maintains a $300,000,000 committed line of credit with 12 banks through which the
company can borrow at rates slightly above LIBOR through May 2000. The company had no borrowings under the committed lines of credit at December 31, 1999.</P>
<P ALIGN="JUSTIFY">The following is a summary of long-term debt:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=415>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>6.70% notes due 2026</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 149,900 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 149,900 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>7.80% mortgage loan</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">4,200 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">5,800 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other long-term debt</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">5,200</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">5,400</U> </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">159,300 </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">161,100 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Less: amounts classified as current:</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">900</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1,100</U> </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total</FONT></TD>
<TD WIDTH="25%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 158,400</U> </FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 160,000</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">The 6.70% notes due 2026 may be redeemed at the option of the note holder on December 1, 2006, at a redemption price equal to the principal amount. The market value of the notes approximates $138,200,000 at
December 31, 1999. Interest expense in 1999, 1998 and 1997 approximated the cash outlay in each year.
At December 31, 1999, the aggregate maturities of long-term debt were as follows: 2000 - $900,000; 2001 - $900,000; 2002 - $900,000; 2003 - $900,000; 2004 - $4,200,000; 2005 and thereafter - $151,500,000.</P>
<P ALIGN="JUSTIFY">Certain of the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s debt agreements contain restrictions that, among other things, require the maintenance of minimum net worth and operating cash flow levels,
limit the amount of debt that the company may have outstanding and contain a material adverse
change clause.</P>
<P ALIGN="JUSTIFY">Under three deposit loan agreements with a bank, $50,000,000 has been borrowed at floating rates (6.76% on average at December 31, 1999) with various maturity dates from December 2002 through June 2005. At maturity, the loans are to be
repaid through matured certificates of deposit held by the </P>
<P ALIGN="CENTER">II-18</P>
<P ALIGN="CENTER">&nbsp;</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">4. Short-Term Borrowings and Long-Term Debt (continued)</P>
<P ALIGN="JUSTIFY">company at the same bank. Because the company has the right of offset under these agreements and it is the company's intention to present these certificates of deposit for repayment of these loans at their maturity, the borrowings have
been offset against these certificates of deposit in the accompanying consolidated balance
sheet at December 31, 1999 and 1998. The related interest income has been offset against the interest expense.</P>
<P ALIGN="JUSTIFY">The company enters into foreign exchange forward contracts and options to help reduce the exposure to fluctuations between certain currencies. At December 31, 1999 there were forward contracts outstanding with a notional amount of
approximately $600,000. These contracts do not create earnings volatility because gains and losses
associated with exchange rate movements are generally offset by movements in the underlying hedged item. At December 31, 1998, there were no forward contracts or options outstanding.</P>
<P ALIGN="JUSTIFY">5. Commitments and Contingencies</P>
<P ALIGN="JUSTIFY">The company is subject to various legal proceedings and claims, including product liability and patent matters and disputes on agreements that arise in the ordinary course of business. The company believes that these legal matters will
likely be disposed of over an extended period of time and should not have a material adverse
impact on the company's consolidated financial position or results of
operations. </P>
<P ALIGN="JUSTIFY">The company is committed under noncancelable operating leases involving certain facilities and equipment. The minimum annual rentals under the terms of these leases are as follows: 2000 - $16,100,000; 2001 - $13,700,000; 2002 -
$11,500,000; 2003 - $10,300,000; 2004 - $8,500,000 and thereafter - $7,900,000. Total rental expense
for all leases approximated $19,600,000 in 1999, $20,100,000 in 1998 and $21,000,000 in 1997.</P>
<P ALIGN="JUSTIFY">6. Stock Rights</P>
<P ALIGN="JUSTIFY">In October 1995 the company's Board of Directors declared a dividend distribution of one Common Share Purchase Right (the "Rights") for each outstanding share of Bard common stock. These Rights, which will expire in October 2005, trade
with the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s
common stock. Such Rights are not presently exercisable and have no voting power. In the event a person acquires 20% or more, or makes a tender or exchange offer for 30% or more of Bard's common stock, the Rights detach from the common stock and become
exercisable and entitle a holder to buy one share of common stock at $120.00 (adjustable to
prevent dilution). </P>
<P ALIGN="JUSTIFY">If, after the Rights become exercisable, Bard is acquired or merged, each Right will entitle its holder to purchase $240 market value of the surviving company's stock for $120, based upon the current exercise price of the Rights. The
company may redeem the Rights, at its option, at $.05 per Right, prior to a public announcement
 that any person has acquired beneficial ownership of at least 20% of Bard</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s common stock. These Rights are designed primarily to encourage anyone interested in acquiring Bard to
negotiate with the Board of Directors. There are 60 million shares of common stock reserved for
issuance upon exercise of the Rights.</P>
<P ALIGN="CENTER">II-19</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">7. Shareholders' Investment</P>
<P ALIGN="JUSTIFY">The company has stock option, stock purchase, stock award and restricted stock plans under which certain directors, officers and employees may receive awards. At December 31, 1999, approximately 1,300,000 shares were reserved for
issuance under these plans.</P>
<P ALIGN="JUSTIFY">Stock Option Plan</P>
<P ALIGN="JUSTIFY">Under the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s stock option plans, options have been granted to certain directors, officers and employees at prices equal to the market value of the shares at
the date of grant and become exercisable over a four- to nine-year period. Certain option
grants in 1997 and all option grants in 1999 have acceleration features based upon performance criteria. During 1999, the company awarded approximately 661,500 performance-accelerated stock options at a price equal to the market value of the shares at the
date of grant. These performance-accelerated stock options become exercisable on their
ninth anniversary after the date of grant or on an accelerated basis when the company reaches the performance criteria.</P>
<P ALIGN="JUSTIFY">The following tables summarize information about stock option activity and amounts:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=507>
<TR><TD WIDTH="48%" VALIGN="TOP">
<P><FONT SIZE=4>&nbsp;</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P>&nbsp;</P>
<P ALIGN="CENTER">Number</P>
<P ALIGN="CENTER">of</P>
<U><P ALIGN="CENTER">Shares </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P ALIGN="CENTER">Weighted</P>
<P ALIGN="CENTER">Average</P>
<P ALIGN="CENTER">Exercise</P>
<U><P ALIGN="CENTER">Price </U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=4><P ALIGN="CENTER">Weighted</P>
<P ALIGN="CENTER">Average</P>
<P ALIGN="CENTER">Fair</P>
<U><P ALIGN="CENTER">Value </U></FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P>Options outstanding December 31, 1996 (1,905,876 exercisable)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3,505,055 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$26.31 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Granted</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">1,024,948 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$37.04</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$11.75</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Exercised</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(714,097)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$22.80</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Canceled</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(155,564</U>)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$29.70</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P>Options outstanding December 31, 1997 (1,769,062 exercisable)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3,660,342 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$29.83</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23><P></P></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Granted</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">754,762 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$40.19</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$12.05</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Exercised</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(872,442)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$27.46</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Canceled</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(189,317</U>)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$34.36</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P>Options outstanding December 31, 1998 (1,905,996 exercisable)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3,353,345 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$32.55</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=23><P></P></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Granted</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">1,432,212 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$49.74</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$15.03</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Exercised</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(704,233)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$30.65</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Canceled</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">(144,510</U>)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$32.20</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="48%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P>Options outstanding December 31, 1999 (2,271,744 exercisable)</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">3,936,814</U> </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=4><P ALIGN="RIGHT">$39.13</FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24><P></P></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-20</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">7. Shareholders' Investment (continued)</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=622>
<TR><TD WIDTH="13%" VALIGN="TOP">
<P><FONT FACE="Garamond">&nbsp;</P>
<P ALIGN="CENTER">Range of</P>
<P ALIGN="CENTER">Exercise</P>
<U><P ALIGN="CENTER">Prices </U></FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">Number</P>
<P ALIGN="RIGHT">Outstanding</P>
<U><P ALIGN="RIGHT">at 12/31/99</U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">Weighed</P>
<P ALIGN="CENTER">Average</P>
<P ALIGN="CENTER">Remaining</P>
<U><P ALIGN="CENTER">Life </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">Weighted</P>
<P ALIGN="CENTER">Average</P>
<P ALIGN="CENTER">Exercise</P>
<U><P ALIGN="CENTER">Price </U></FONT></TD>
<TD WIDTH="16%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">Number</P>
<P ALIGN="RIGHT">Exercisable</P>
<U><P ALIGN="RIGHT">at 12/31/99</U></FONT></TD>
<TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">Weighed</P>
<P ALIGN="CENTER">Average</P>
<P ALIGN="CENTER">Exercise</P>
<U><P ALIGN="CENTER">Price </U></FONT></TD>
</TR>
<TR><TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>$10 to 30</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">877,513 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">3.7</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$25.72</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">871,763 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$25.70</FONT></TD>
</TR>
<TR><TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>$30 to 35</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">393,787 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">5.8</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$32.85</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">298,422 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$32.84</FONT></TD>
</TR>
<TR><TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>$35 to 40</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">702,734 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">6.5</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$37.11</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">549,906 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$37.10</FONT></TD>
</TR>
<TR><TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>$40 to 45</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">553,773 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">7.8</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$40.36</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">551,373 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$40.36</FONT></TD>
</TR>
<TR><TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>$45 to 50</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">736,257 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">9.5</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$48.12</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">280 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$48.06</FONT></TD>
</TR>
<TR><TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>$50 to 75</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">672,750</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">9.1</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$51.55</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">0</U> </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$ 0.00</FONT></TD>
</TR>
<TR><TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>$10 to 75</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">3,936,814 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">7.0</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$39.13</FONT></TD>
<TD WIDTH="16%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">2,271,744 </FONT></TD>
<TD WIDTH="17%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="CENTER">$32.96</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">In accordance with Statement of Financial Accounting Standards No. 123, </FONT><FONT FACE="WP TypographicSymbols">A</FONT><FONT FACE="Garamond">Accounting for Stock-Based Compensation</FONT><FONT FACE="WP
TypographicSymbols">@</FONT><FONT FACE="Garamond"> (</FONT><FONT FACE="WP TypographicSymbols">A</FONT><FONT
FACE="Garamond">FAS 123"), the fair value of option grants is estimated on the date of grant using the Black-Scholes option-pricing model for pro forma disclosure purposes.</P>
<P ALIGN="JUSTIFY">In 1997 the dividend yield was assumed to be 2%, the risk-free interest rate was 6.2%, the expected option life was 6 years and the expected volatility was 26%. In 1998 the dividend yield was assumed to be 2%, the risk-free interest
rate was 4.75%, the expected option life was 5.8 years and the expected volatility was 29%. In 1999 the
dividend yield rate was assumed to be 2%, the risk-free interest rate was 6.58%, the expected option life was 5.2 years and the expected volatility was 28%.</P>
<P ALIGN="JUSTIFY">As permitted by FAS 123, the company has chosen to continue accounting for stock options at their intrinsic value. Accordingly no compensation expense has been recognized for its stock option plans. Had the fair value method of
accounting been applied to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s
stock option plans, the tax affected impact would be as follows:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=513>
<TR><TD WIDTH="44%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">(thousands of dollars except per share amounts)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="44%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net income as reported</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$118,100 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$252,300 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 72,300 </FONT></TD>
</TR>
<TR><TD WIDTH="44%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Pro forma net income</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$111,300 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$247,400 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 69,100 </FONT></TD>
</TR>
<TR><TD WIDTH="44%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Diluted earnings per share as reported</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 2.28 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 4.51 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 1.26 </FONT></TD>
</TR>
<TR><TD WIDTH="44%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Pro forma diluted earnings per share</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 2.15 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 4.42 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 1.21 </FONT></TD>
</TR>
</TABLE>

<U><FONT FACE="Garamond"><P ALIGN="JUSTIFY">&nbsp;</P>
</U><P ALIGN="CENTER">II-21</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">7. Shareholders' Investment (continued)</P>
<P ALIGN="JUSTIFY">This pro forma impact takes into account only options granted since January 1, 1995 and increases as additional options are granted and amortized ratably over the vesting period.</P>
<P ALIGN="JUSTIFY">Stock Purchase Plan</P>
<P ALIGN="JUSTIFY">Under the company's management stock purchase plan, management-level employees are granted the right to purchase the company's stock at a discount. Shares are reserved at the date of purchase entitling the participants to dividends and
the right to vote their respective shares. Restrictions limit the sale or transfer of these shares during
a three-year period from the purchase date. In 1999 employees purchased approximately 122,000 shares at a per share price of $28.43. The company recorded compensation expense related to current and anticipated stock purchases of $1,300,000 and $700,000
for the years ended December 31, 1999 and 1998, respectively. The unamortized portion was $800,000 at December
31, 1999.</P>
<P ALIGN="JUSTIFY">Stock Award Plan</P>
<P ALIGN="JUSTIFY">Under the company's stock award plans for key employees and directors, shares are granted at no cost to the recipients and distributed in three separate installments. During 1999, awards for approximately 21,400 shares were granted and
20,800 shares were issued. Awards are charged to income over a three-year vesting period. At December 31, 1999,
approximately 20,900 awarded shares (aggregate market price at date of grant $958,000) have not been issued.</P>
<P ALIGN="JUSTIFY">Restricted Stock Plan</P>
<P ALIGN="JUSTIFY">Under the company's restricted stock plan, common stock may be granted at no cost to certain management-level employees. Shares are issued to the participants at the date of grant entitling the participants to dividends and the right to
vote their respective shares. Restrictions limit the sale or transfer of these shares during a five-year period
from the grant date. During 1999, 1998 and 1997 the company granted approximately 82,000, 95,000 and 51,000 shares, respectively, of restricted stock to eligible employees. The fair value of these restricted shares at the date of grant is amortized to
expense ratably over the restriction period. The company recorded compensation expense related to restricted stock of
$2,000,000, $2,900,000 and $1,600,000 for the years ended December 31, 1999, 1998 and 1997, respectively. The unamortized portion was $7,000,000, $5,300,000 and $4,900,000 at December 31, 1999, 1998 and 1997 respectively.</P>
<P ALIGN="JUSTIFY">Performance-Accelerated Restricted Stock Plan</P>
<P ALIGN="JUSTIFY">Under the company's performance-accelerated restricted stock plan, common stock may be granted at no cost to certain officers. Shares are issued to the participants at the date of grant entitling the participants to dividends and the
right to vote their respective shares. Restrictions that limit the sale or transfer of these shares expire five years
after the company achieves the performance criteria. During 1999 and 1997 the company granted 152,000 and 130,000 shares, respectively, of performance-accelerated restricted stock to eligible employees. The estimated fair value of the perfo
rmance-accelerated restricted shares is adjusted and amortized to expense ratably over the restriction period. The company recorded
compensation expense related to performance-accelerated restricted stock of $1,900,000, $2,200,000 and $400,000 in 1999, 1998 and 1997, respectively. The unamortized portion was $9,000,000, $2,800,000, and $5,400,000 at December 31, 1999, 1998 and 1997,
respectively. As of December 31, 1999, 152,000 shares continued to be subject to performance restrictions.</P>
<P ALIGN="CENTER">II-22</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</P>
</U><P ALIGN="JUSTIFY">8. Postretirement Benefits</P>
<P ALIGN="JUSTIFY">The company has defined benefit pension plans that cover substantially all domestic and certain foreign employees. These plans provide benefits based upon a participant's compensation and years of service. In addition, the company has a
defined contribution plan covering substantially all domestic employees and a supplemental defined contribution plan
for certain officers and key employees. The amounts charged to income for these plans amounted to $10,900,000 in 1999; $13,500,000 in 1998 and $14,100,000 in 1997.</P>
<P ALIGN="JUSTIFY">The following tables set forth information relative to the company's defined benefit plans:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=452>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>CHANGE IN PROJECTED BENEFIT OBLIGATION</P>
<P>AS OF SEPTEMBER 30:</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>&nbsp;</P>
<P>&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Projected benefit obligation as of previous year</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$137,100 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$127,100 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Service cost</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">7,000 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">8,300 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Interest cost</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">8,000 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">8,800 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Curtailment</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(1,400)</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Special termination benefits</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">3,900 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Divestitures</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(13,700)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(10,300)</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Actuarial (gain)/loss</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">3,700 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">10,200 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Benefits paid</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(18,900)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(10,600)</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(200</U>)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1,100</U> </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Projected benefit obligation as of current year</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$123,000</U> </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$137,100</U> </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>CHANGE IN PLAN ASSETS AS OF SEPTEMBER 30:</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Fair value as of previous year</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$129,100 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$123,200 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Actual return</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">17,600 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">4,800 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Company contribution</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">12,600 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">21,000 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Divestitures</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(13,700)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(10,800)</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Benefits paid</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(18,900)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(10,600)</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(100</U>)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1,500</U> </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Fair value as of current year</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$126,600</U> </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$129,100</U> </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>FUNDED STATUS AS OF DECEMBER 31:</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>As of current year end</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 3,600 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ (8,000)</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Unrecognized net (gain)/loss</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">2,700 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">9,100 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Unrecognized prior service cost</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">3,000 </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">3,500 </FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Unrecognized net transition (asset) obligation</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(600</U>)</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(700</U>)</FONT></TD>
</TR>
<TR><TD WIDTH="52%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Prepaid (accrued) pension obligation</FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 8,700</U> </FONT></TD>
<TD WIDTH="24%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 3,900</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="CENTER">II-23</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</U> </P>
<P ALIGN="JUSTIFY">8.&#9;Postretirement Benefits (continued)</P>
<P ALIGN="JUSTIFY">Pension costs related to the defined benefit pension plans for the years ended December 31, 1999, 1998 and 1997 are as follows:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=488>
<TR><TD WIDTH="41%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="41%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Service cost</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 7,000 </FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 8,300 </FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 8,000 </FONT></TD>
</TR>
<TR><TD WIDTH="41%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Interest cost</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">8,000 </FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">8,800 </FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">8,100 </FONT></TD>
</TR>
<TR><TD WIDTH="41%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Expected return on plan assets</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(9,300)</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(9,000)</FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(7,500)</FONT></TD>
</TR>
<TR><TD WIDTH="41%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">2,100 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">800 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">800 </U></FONT></TD>
</TR>
<TR><TD WIDTH="41%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net periodic pension cost</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 7,800 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 8,900 </U></FONT></TD>
<TD WIDTH="18%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 9,400 </U></FONT></TD>
</TR>
</TABLE>

<P ALIGN="JUSTIFY"></P>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=537>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond" SIZE=1>Weighted Average Assumptions:</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1999 </U></FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1998 </U></FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Discount rate</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">7.13%</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">6.48%</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">7.34%</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Expected return on plan assets</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">8.93%</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">8.94%</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">8.91%</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P>Rate of compensation increase</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">4.86%</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">4.22%</FONT></TD>
<TD WIDTH="20%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=1><P ALIGN="CENTER">5.15%</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">The company does not provide postretirement health care benefits and life insurance coverage except to a limited number of former employees. The amounts charged to income for this plan were approximately $700,000
in 1999, $720,000 in 1998 and $550,000 in 1997. The accumulated postretirement benefit obligation included in other
long-term liabilities amounted to $10,600,000 and $11,000,000 for the years ended December 31, 1999 and December 31, 1998, respectively.</P>
<P ALIGN="JUSTIFY">Actuarial assumptions included a discount rate of 7.25% and an ultimate health care cost trend rate of 5%. The effect of a 1% annual increase in the assumed cost trend rate would increase the accumulated postretirement benefit
obligation at December 31, 1999 by $980,000 and postretirement benefit cost by $64,000.</P>
<P ALIGN="JUSTIFY">9. Other (Income) Expense, Net</P>
<P ALIGN="JUSTIFY">During 1997, the company initiated a plan to restructure its global manufacturing operations. This plan resulted in a charge of $44,100,000 exclusive of certain period costs that are expensed as incurred. In connection with the
disposition of the company's cardiology businesses in 1998, certain changes were made to the company's restructuring plan.
As a result of the changes, a net additional charge of $3,200,000 was recorded. As of December 31, 1999, seven facilities have been shut down. These restructuring plans have impacted approximately 1,000 positions worldwide. The majority of the
restructuring activities have been completed; however, there are still certain activities and final payments to be completed
in 2000. At December 31, 1999, the reserve balance relating to these restructuring plans amounted to $8,600,000 primarily comprising severance costs associated with a facility that has not been closed.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-24</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</U> </P>
<P ALIGN="JUSTIFY">9. Other (Income) Expense, Net (continued)</P>
<P ALIGN="JUSTIFY">Since the implementation of these restructuring plans, the restructuring accruals have decreased by $38,700,000 due to cash expenditures of approximately $17,400,000, primarily for severance, related personnel benefits and facility
closure costs and noncash charges of approximately $21,300,000 to reduce the carrying value of certain assets related to
manufacturing operations.</P>
<P ALIGN="JUSTIFY">During 1999, the company recorded a charge of $9,700,000 related to investments made in several ventures that are no longer deemed to be financially viable. The net after-tax effect of this charge amounted to $6,300,000 ($.12 per share
after tax).</P>
<P ALIGN="JUSTIFY">Other income and expense for 1998 includes a net gain of $48,600,000 from the settlement of patent infringement claims netted by other legal and patent settlements. Also included is a charge of $34,100,000 for the writedown of several
businesses and investments (including the loss on the sale of the Diagnostic Sciences Division), a charge of $6,400,000
related to acquired R&amp;D and a charge of $10,100,000 related to other items including a charge related to the retiring of $60 million of long-term debt. The net after-tax effect of these items and the 1998 restructuring charge discussed above amounted
to an after-tax loss of $7,100,000 ($.13 per share after tax).</P>
<P ALIGN="JUSTIFY">In addition to the manufacturing restructuring reserve noted above, other income and expense for 1997 includes a gain of $24,500,000 principally from the sale of several product lines, a charge for the impairment of certain investments
and intangible assets of $8,500,000 and the settlement of a legal claim of $2,000,000. The net after-tax effect of these
items amounted to a loss of $21,700,000 ($.38 per share after tax).</P>
<P ALIGN="JUSTIFY">Other (income) expense, net in the Statements of Consolidated Income is summarized as follows:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=482>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Interest income</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ (2,100)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ (6,000)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ (3,500)</FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Foreign exchange (gains) losses</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(900)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(2,100)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Legal and patent settlements, net</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(48,600)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">2,000 </FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Asset writedown</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">9,700 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">34,100 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">8,500 </FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Restructuring</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">3,200 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">44,100 </FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Gains from sale of product lines and other</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">(24,500)</FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Acquired R&amp;D</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">6,400 </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">- - - </FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other, net</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">(200</U>)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">10,100</U> </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">- - -</U> </FONT></TD>
</TR>
<TR><TD WIDTH="42%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 6,500</U> </FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ (2,900</U>)</FONT></TD>
<TD WIDTH="19%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$ 26,600</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>&nbsp;&nbsp;</P>
<P ALIGN="CENTER">II-25</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P ALIGN="CENTER">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</U> </P>
<P>10. Segment Information</P>
<P ALIGN="JUSTIFY">The company's management considers its business to be a single segment entity - the manufacture and sale of medical devices. The company's products generally share similar distribution channels and customers. The company designs,
manufactures, packages, distributes and sells medical, surgical, diagnostic and patient care devices which, for the most
part, are purchased by hospitals, physicians and nursing homes; used once and discarded. Management evaluates its various global product portfolios on a revenue basis, which is presented below, and profitability is generally evaluated on an
enterprise-wide basis due to shared infrastructures.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=488>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond">(thousands of dollars)</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Sales:</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24><P></P></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Vascular</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 226,200</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 209,000</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 198,000</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Urology</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">353,600</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">339,800</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">323,400</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Oncology</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">238,000</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">213,100</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">199,100</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Surgery</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">164,500</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">148,400</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">134,800</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Other ongoing products</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">54,200</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">58,600</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">58,200</U></FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total ongoing products</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">1,036,500</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">968,900</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">913,500</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Divested products</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">0</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">195,800</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">300,000</U></FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Net sales</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,036,500</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,164,700</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond"><P ALIGN="RIGHT">$1,213,500</U></FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Income before taxes</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 173,300</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 464,400</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 104,900</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Total Assets</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,126,400</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,079,800</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,279,300</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Capital Expenditures</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 26,100</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 43,800</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 32,800</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P>Depreciation and Amortization</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 49,100</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 58,700</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 57,300</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>The following table presents sales of ongoing products by geography based on the location of the external customer:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=488>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond" SIZE=2>(thousands of dollars)</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>United States</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 736,700</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 687,900</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 652,600</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Europe</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">193,400</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">182,700</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">171,300</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Japan</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">49,300</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">50,300</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">42,900</FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Rest of World</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">57,100</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">48,000</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">46,700</U></FONT></TD>
</TR>
<TR><TD WIDTH="34%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Total</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$1,036,500</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 968,900</U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 913,500</U></FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond" SIZE=2><P>The following table presents identifiable assets by geography:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=482>
<TR><TD WIDTH="35%" VALIGN="TOP" HEIGHT=24>
<P><FONT FACE="Garamond" SIZE=2>(thousands of dollars)</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">1999 </U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">1998 </U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">1997 </U></FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>United States</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 808,400</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 767,000</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$ 844,700</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Europe</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">241,100</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">224,100</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">332,600</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Japan</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">300</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">3,900</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">18,100</FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Rest of World</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">76,600</U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">84,800</U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">83,900</U></FONT></TD>
</TR>
<TR><TD WIDTH="35%" VALIGN="TOP" HEIGHT=24>
<FONT FACE="Garamond" SIZE=2><P>Total</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$1,126,400</U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$1,079,800</U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=24>
<U><FONT FACE="Garamond" SIZE=2><P ALIGN="RIGHT">$1,279,300</U></FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="CENTER">II-26</P>
<U><P>QUARTERLY FINANCIAL DATA</P>
<P>C. R. BARD, INC. AND SUBSIDIARIES</P></U></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=623>
<TR><TD WIDTH="32%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="68%" VALIGN="TOP" COLSPAN=5>
<FONT FACE="Garamond" SIZE=2><P>&nbsp;</P>
<U><P ALIGN="CENTER">1999 </U></FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>(thousands of dollars except</P>
<P>per share amounts)</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">1st</U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">2nd</U></FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">3rd</U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">4th</U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">Year</U></FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Net sales</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 248,500</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 257,800</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 259,500</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 270,700</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,036,500</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Cost of goods sold</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">109,400</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">114,500</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">116,200</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">122,200</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">462,300</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Income before taxes</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">39,900</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">41,400</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">43,900</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">48,100</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">173,300</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Net income</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">26,600</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">28,200</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">30,100</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">33,200</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">118,100</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Per share information:</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="13%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="14%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="13%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;Basic earnings per share</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .52</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .55</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .59</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .65</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 2.31</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Diluted earnings per share</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .51</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .55</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .58</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .64</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 2.28</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">Note: The fourth quarter included a gain of $9,200 ($.12 per share after tax) for the sale of the company's cardiopulmonary business and a charge of $8,400 ($.11 per share after tax) for asset impairments. </P></FONT>

<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=8 WIDTH=622>
<TR><TD WIDTH="32%" VALIGN="TOP">
<P><FONT FACE="Garamond">&nbsp;</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="68%" VALIGN="TOP" COLSPAN=5>
<FONT FACE="Garamond"><P>&nbsp;</P>
<U><P ALIGN="CENTER">1998 </U></FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>(thousands of dollars except per share amounts)</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">1st</U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">2nd</U></FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">3rd</U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">4th</U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P ALIGN="CENTER">Year</U></FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Net sales</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 296,300</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 300,600</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 298,500</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 269,300</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$1,164,700</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Cost of goods sold</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">140,900</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">144,600</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">144,900</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">123,700</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">554,100</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Income before taxes</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">36,300</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">62,200</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">34,100</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">331,800</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">464,400</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Net income</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">24,900</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">40,200</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">23,500</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">163,700</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">252,300</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Per share information:</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">&nbsp;</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>&nbsp;Basic earnings per share</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .44</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .71</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .42</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 3.06</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 4.54</FONT></TD>
</TR>
<TR><TD WIDTH="32%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Diluted earnings per share</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .44</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .71</FONT></TD>
<TD WIDTH="14%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ .42</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 3.03</FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">$ 4.51</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">Note: The second quarter included a net pretax gain of $61,800 ($.65 per share after tax) for legal and patent settlements, a charge of $24,100 ($.25 per share after tax) primarily for discontinued operations and a
charge of $6,500 ($.07 per share after tax) for other nonrecurring charges including the cost of retiring $60,000 of
long-term debt. The fourth quarter included a gain of $329,200 ($3.03 per share after tax) for the net gain on cardiology dispositions and a net charge of $13,200 ($.15 per share after tax), $10,000 ($.12 per share after tax), $6,400 ($.10 per share after
tax) and $6,800 ($.11 per share after tax) related to legal settlements, discontinued businesses, acquired research
and development and other nonrecurring charges, respectively.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">II-27</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P>Item 9.</U> <U>Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</P>
</U><P>Not applicable.</P>
<P>&nbsp;&nbsp;</P>
<P ALIGN="CENTER">II-28</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
</U><P ALIGN="CENTER">&#9;<U>PART III</P>
<P>Item 10.</U> <U>Directors and Executive Officers of the Registrant</P>
<P>Directors of the Registrant</P>
</U><P>Information with respect to Directors of the company is incorporated herein by reference to the material contained under the heading "Proposal No. 1 - Election of Directors" appearing on pages 1 through 4 of the company's definitive Proxy Statement
dated March 10, 2000.</P>
<U><P>Executive Officers of the Registrant</P>
</U><P>Information with respect to Executive Officers of the Registrant are on pages I-7 through I-9 of this filing.</P>
<U><P>Item 11.</U> <U>Executive Compensation</P>
</U><P>The information contained under the caption "Executive Compensation" appearing on Pages 7 through 19 of the company's definitive Proxy Statement dated March 10, 2000 is incorporated herein by reference.</P>
<P>&nbsp;<U>Item 12.</U> <U>Security Ownership of Certain Beneficial Owners and Management</P>
</U><P>The information contained under the captions "Securities Ownership of Certain Beneficial Owners" and "Securities Ownership of Management" on pages 5 and 6 of the company's definitive Proxy Statement dated March 10, 2000 is incorporated herein by
reference.</P>
<P>&nbsp;<U>Item 13.</U> <U>Certain Relationships and Related Transactions</P>
</U><P>The information contained under the caption "Related Transactions" on page 17 of the company's definitive Proxy Statement dated March 10, 2000 is incorporated herein by reference.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">III-1</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
</U><P>&#9;<U>PART IV</P><DIR>
<DIR>
<DIR>
<DIR>

<P>Item 14.</U>&#9;<U>Exhibits, Financial Statement Schedules, and Reports on Form 8-K</P></DIR>
</DIR>
</DIR>
</DIR>

</U><P>(a)&#9;l.&#9;<U>Financial Statements and Supplementary Data</P>
</U><P>Included in Part II Item 8 of this report:</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=6 WIDTH=570>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<P><U><FONT FACE="Garamond">Page</U></FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36><P></P></TD>
</TR>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>II- 9&#9;</FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>Report of Independent Public Accountants.</FONT></TD>
</TR>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>II-10</FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>Consolidated Statements of Income for the years ended December 31, 1999, 1998 and 1997.</FONT></TD>
</TR>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>II-11</FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>Consolidated Statements of Shareholders' Investment for the years ended December 1999, 1998 and 1997</FONT></TD>
</TR>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>II-12</FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>Consolidated Balance Sheets at December 31, 1999 and 1998.</FONT></TD>
</TR>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>II-13</FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>Consolidated Statements of Cash Flows for the years ended December 31, 1999, 1998 and 1997.</FONT></TD>
</TR>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>II-14</FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>Notes to Consolidated Financial Statements.</FONT></TD>
</TR>
<TR><TD WIDTH="12%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>II-27</FONT></TD>
<TD WIDTH="88%" VALIGN="TOP" HEIGHT=36>
<FONT FACE="Garamond"><P>Quarterly Financial Data.</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>2.&#9;<U>Financial Statement Schedules</P><DIR>
<DIR>

</U><P>Schedules are omitted because they are not applicable, are not required or the information required is included in the financial statements or notes thereto.</P></DIR>
</DIR>
</FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=570>
<TR><TD WIDTH="17%" VALIGN="TOP">
<P ALIGN="CENTER"><U><FONT FACE="Garamond">No</U>.</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Exhibits</U></FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">3a</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Registrant's Restated Certificate of Incorporation, as amended, as of April 17, 1996, filed as Exhibit 3 to the company's September 30, 1996 Form 10-Q is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">3b</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Registrant's Bylaws amended as of December 8, 1999 (p. IV-8 ).</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">4a</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Rights Agreement dated as of October 11, 1995 between C. R. Bard, Inc. and First Chicago Trust Company of New York as Rights Agent, filed as Exhibit 1 to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT
FACE="Garamond">s Registration Statement on Form 8-A filed with the Securities and Exchange Commission on October 12, 1995, is
incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">4b</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Indenture, dated as of December 1, 1996 between C. R. Bard, Inc. and The Chase Manhattan Bank, as trustee, filed as Exhibit 4.1 to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s Registration
Statement on Form S-3, File No. 333-05997, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>William H. Longfield Change of Control Agreement, dated as of July 12, 1989, as amended as of July 13, 1994, filed as Exhibit 10b to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s 1994 Annual
Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10a*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Hope Greenfield Change of Control Agreement dated as of March 6, 1996, filed as Exhibit 10d to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s 1995 Annual Report on Form 10-K, is incorporated
herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10b*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>E. Robert Ernest Change of Control Agreement, dated as of January 12, 1991, as amended as of July 19, 1994, filed as Exhibit 10f to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s 1994 Annual
Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10c*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. Supplemental Executive Retirement Agreement with William H. Longfield effective as of January 12, 1994, filed as Exhibit 10g to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.
</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10d*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. 1990 Stock Option Plan, filed as Exhibit 10h to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10e*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. 1989 Employee Stock Appreciation Rights Plan, filed as Exhibit 10i to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10f*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. Agreement and Plans Trust, amended and restated as of February 8, 1989, filed as Exhibit 10j to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10g*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Forms of Supplemental Insurance/Retirement Plan, Plan I - For new corporate officer when previous agreement as non-officer exists, Plan II - For new corporate officer when no previous agreement exists, filed as Exhibit 10k to the
company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10h*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Stock Equivalent Plan For Outside Directors of
C. R. Bard, Inc., dated as of January 1, 1997, filed as Exhibit 10h to the
company's 1999 Annual Report on Form 10-K, is incorporated herein by
reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10i*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Deferred Compensation Contract Deferral of Directors' Fees, as amended, between C. R. Bard, Inc. and William T. Butler, M.D., Regina E. Herzlinger, and Robert P. Luciano, filed as Exhibit 10m to the company's 1993 Annual Report on
Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10j*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>1988 Directors Stock Award Plan of C. R. Bard, Inc., as amended in April 1998, filed as Exhibit 10ae to the company's 1998 Quarterly Report on Form 10 - Q for the quarter ended March 31, 1998, File No. 1-6926, is incorporated
herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10k*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. Excess Benefit Plan as of July 13, 1988, filed as Exhibit 10o to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10l*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. Supplemental Executive Retirement Plan, dated as of July 13, 1988, filed as Exhibit 10p to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10m*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. 1994 Executive Bonus Plan, filed as Exhibit 10 to the company's Quarterly Report on Form 10-Q for the quarter ended March 31, 1994, File No. 1-6926, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10n*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. Long Term Performance Incentive Plan effective as of January 1, 1977, filed as Exhibit 10r to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10o*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Forms of Deferred Compensation Contract Deferral of Discretionary Bonus, filed as Exhibit 10s to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10p*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Forms of Deferred Compensation Contract Deferral of Salary, filed as Exhibit 10t to the company's 1993 Annual Report on Form10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10q*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>1993 Long Term Incentive Plan of C. R. Bard, Inc., as amended effective April 15, 1998, filed as Exhibit 10ad to the company's 1998 Quarterly Report on Form 10-Q for the quarter ended March 31, 1998, File No. 1-6926, is
incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10r*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Earle L. Parker Change of Control Agreement, dated as of June 29, 1994, filed as Exhibit 10v to the company's 1994 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10s*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>John H. Weiland Change of Control Agreement, dated as of March 11, 1996, filed as Exhibit 10w to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s 1995 Annual Report on Form 10-K, is incorporated
herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10t*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Timothy M. Ring Change of Control Agreement, dated as of March 12, 1996, filed as Exhibit 10y to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s 1995 Annual Report on Form 10-K, is incorporated
herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10u*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Guy J. Jordan Change of Control Agreement , dated as of October 10, 1996, filed as Exhibit 10z to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s 1996 Annual Report on Form 10-K, is
incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10v*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Charles P. Grom Change of Control Agreement, dated as of December 11, 1996, filed as Exhibit 10aa to the company</FONT><FONT FACE="WP TypographicSymbols">=</FONT><FONT FACE="Garamond">s 1996 Annual Report on Form 10-K, is
incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10w*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Richard D. Manthei Change of Control Agreement, dated as of February 11, 1998 filed as Exhibit 10ab to the company's 1997 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10x*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Nadia C. Adler Change of Control Agreement,
dated as of February 8, 1999, filed as Exhibit 10x to the company's 1998
Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10y*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Charles P. Slacik Change of Control Agreement,
dated as of January 6, 1999, filed as Exhibit 10y to the company's 1998
Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10z*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. Bard, Inc. Management Stock Purchase Plan, amended as of December 8, 1999 (p. IV-16).</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10aa*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>1998 Employee Stock Purchase Plan (p. IV-18).</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">10ab*</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Retirement Plan for Outside Directors of C. R. Bard, Inc., amended and restated as of September 9, 1992 (p. IV-24).</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">12.1</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Computation in Support of Ratio of Earnings to Fixed Charges </P>
<P>(p. IV-30).</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">21</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Subsidiaries of registrant (p. IV-31).</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">23</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Arthur Andersen LLP consent to the incorporation by reference of their report on Form 10-K into previously filed Forms S-8 and S-3 (p. IV-33).</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">27</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Financial data schedule.</FONT></TD>
</TR>
<TR><TD WIDTH="17%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">99</FONT></TD>
<TD WIDTH="83%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Indemnity agreement between the company and each of its directors and officers, filed as Exhibit 99 to the company's 1993 Annual Report on Form 10-K, is incorporated herein by reference.</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">&#9;&#9;</P>
<P>&nbsp;*&#9;Each of these exhibits listed under the number 10 constitutes a management contract or a compensatory plan or arrangement.</P>
<P ALIGN="JUSTIFY">All other exhibits are not applicable.</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-4</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
</U><P ALIGN="JUSTIFY">&nbsp;</P>
<P>(b) <U>Reports on Form 8-K</P><DIR>
<DIR>
<DIR>

</U><P>(b)&#9;No reports on Form 8-K were filed by the Registrant during the three months ended December 31, 1999.</P></DIR>
</DIR>
</DIR>

<P ALIGN="CENTER">IV-5</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
</U><P ALIGN="CENTER">Signatures</P>
<P>Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=624>
<TR><TD WIDTH="33%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="33%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>C. R. BARD, INC.</P>
<P>(Registrant)</FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="RIGHT">By:</FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Charles P. Slacik /s/</P>
</U><P>Charles P. Slacik</P>
<P>Senior Vice President and</P>
<P>Chief Financial Officer</FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Date: March 28, 2000</FONT></TD>
<TD WIDTH="33%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="33%" VALIGN="TOP">
<P>&nbsp;</TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=637>
<TR><TD WIDTH="33%" VALIGN="TOP">
<P><U><FONT FACE="Garamond">Signatures </U></FONT></TD>
<TD WIDTH="45%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Title </U></FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Date </U></FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>William H. Longfield /s/</FONT></TD>
<TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Chairman and</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Garamond"><P>March 28, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>William H. Longfield</FONT></TD>
<TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Chief Executive Officer and Director</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<P>&nbsp;</TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<P>&nbsp;</TD>
<TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>(Principal Executive Officer)</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<P>&nbsp;</TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Charles P. Slacik /s/</FONT></TD>
<TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Senior Vice President and</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Garamond"><P>March 28, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Charles P. Slacik</FONT></TD>
<TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Chief Financial Officer</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<P>&nbsp;</TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP" HEIGHT=19><P></P></TD>
<TD WIDTH="45%" VALIGN="TOP" HEIGHT=19>
<FONT FACE="Garamond"><P>(Principal Financial Officer)</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP" HEIGHT=19><P></P></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Charles P. Grom /s/</FONT></TD>
<TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Vice President and Controller</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<FONT FACE="Garamond"><P>March 28, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="33%" VALIGN="TOP">
<FONT FACE="Garamond"><P>Charles P. Grom</FONT></TD>
<TD WIDTH="45%" VALIGN="TOP">
<FONT FACE="Garamond"><P>(Principal Accounting Officer)</FONT></TD>
<TD WIDTH="22%" VALIGN="TOP">
<P>&nbsp;</TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-6</P>
<U><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P></U></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=621>
<TR><TD WIDTH="40%" VALIGN="TOP" HEIGHT=29>
<P><FONT FACE="Garamond">&nbsp;</P>
<U><P>Signatures </U></FONT></TD>
<TD WIDTH="30%" VALIGN="TOP" HEIGHT=29>
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<U><P ALIGN="CENTER">Title </U></FONT></TD>
<TD WIDTH="31%" VALIGN="TOP" HEIGHT=29>
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<U><P ALIGN="CENTER">Date </U></FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Marc C. Breslawsky /s/ </P>
</U><P>Marc C. Breslawsky</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>William T. Butler, M.D. /s/ </P>
</U><P>William T. Butler, M.D.</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Elaine L. Chao /s/ </P>
</U><P>Elaine L. Chao</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>T. Kevin Dunnigan /s/ </P>
</U><P>T. Kevin Dunnigan</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Regina E. Herzlinger /s/ </P>
</U><P>Regina E. Herzlinger</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Robert P. Luciano /s/ </P>
</U><P>Robert P. Luciano</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Anthony Welters /s/ </P>
</U><P>Anthony Welters</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
<TR><TD WIDTH="40%" VALIGN="TOP">
<U><FONT FACE="Garamond"><P>Tony L. White /s/ </P>
</U><P>Tony L. White</P>
<P>&nbsp;</P>
<P>&nbsp;</FONT></TD>
<TD WIDTH="30%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">Director</FONT></TD>
<TD WIDTH="31%" VALIGN="TOP">
<FONT FACE="Garamond"><P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">March 21, 2000</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P ALIGN="CENTER">IV - 7</P>
</FONT><FONT FACE="Courier"><P ALIGN="CENTER">&nbsp;</P></FONT></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3
<SEQUENCE>2
<TEXT>

<HTML>
<HEAD>
<TITLE>BY LAWS</TITLE>
</HEAD>
<BODY>

<FONT FACE="Garamond"><P ALIGN="JUSTIFY">Exhibit 3b</P>
</FONT><B><FONT SIZE=2><P ALIGN="CENTER">BY-LAWS</P>
<P ALIGN="CENTER">of</P>
<P ALIGN="CENTER">C. R. BARD, INC.</P>
<P ALIGN="CENTER">(A New Jersey Corporation)</P>
<P ALIGN="CENTER">(Amended December&nbsp;8, 1999)</P>
</B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">&nbsp;</P>
<B><P ALIGN="CENTER">ARTICLE&nbsp;I</P>
</B><P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Offices</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;The principal office of the Corporation shall be in the
Borough of New Providence, County of Union, State of New Jersey. The Corporation
 may also establish and have such other offices as needed for the conduct of its
 business at such other place or places within or without the state of New Jersey
 as may from time to time be designated by the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">ARTICLE&nbsp;II</P>
</B><P ALIGN="CENTER"></P>
<B><P ALIGN="CENTER">Seal</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;The Corporate seal shall have inscribed thereon the name of
the Corporation, the year of its organization, and the words, "CORPORATE SEAL, NEW JERSEY".</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">ARTICLE&nbsp;III</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Stockholders' Meetings</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 1.  <I>Place of Meetings.  </I>Meetings of the stockholders
 may be held at the principal office in New Jersey or at such other place within or without
the State of New Jersey as from time to time may be designated by the Board of Directors and
stated in the notice of meeting.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 2.  <I>Annual Meetings.  </I>The annual meeting of stockholders
for the election of Directors and the transaction of such other business as may properly be
brought before the meeting shall be held on the third Wednesday in April in each year or such
 other date as shall be designated by the Board of Directors. If this date shall fall upon a
legal holiday, the meeting shall be held on the next succeeding business day which is not a legal holiday.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 3.  <I>Business Transacted</I>-Annual Meetings.  At any annual
meeting of the stockholders of the Corporation, only such business shall be conducted as shall
have been brought before the meeting (a)&nbsp;by or at the direction of the Board of Directors
or (b)&nbsp;by any stockholder of the Corporation who complies with the procedures set forth in
this Section&nbsp;3. For business properly to be brought before an annual meeting by a stockholder,
 the stockholder must have given timely notice thereof in proper written form to the Secretary of the
 Corporation. To be timely, a stockholder's notice must be delivered to or mailed and received at the
principal executive offices of the Corporation not less than 90&nbsp;days nor more than 120&nbsp;days
prior to the first anniversary of the preceding year's annual meeting; provided, however, that in the
event that the date of the annual meeting is more than 30 days before or more than 60 days after such
anniversary date, notice by the stockholder to be timely must be so received not later than the close of
 business on the 10th day following the day on which public announcement of the date of the annual meeting
 is first made. To be in proper written form, a stockholder's notice to the Secretary shall set forth in
writing as to each matter the stockholder proposes to bring before the annual meeting (a)&nbsp;a brief
description of the business desired to be brought before the annual meeting and the reasons for conducting
such business  at   the  annual  meeting,  (b) the name and address, as they appear on the Corporation's books,
of the stockholder</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="CENTER">IV-8</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">proposing such business, (c)&nbsp;the class and number of shares of the Corporation which
are beneficially owned by the stockholder and (d)&nbsp;any material interest of the stockholder in such business.
 Notwithstanding anything in the By-Laws to the contrary, no business shall be conducted at an annual meeting except
 in accordance with the procedures set forth in this Section&nbsp;3. The chairman of an annual meeting shall, if the
facts warrant, determine and declare to the meeting that business was not properly brought before the meeting in
accordance with the provisions of this Section&nbsp;3, and, if he should so determine, he shall so declare to the
meeting and any such business not properly brought before the meeting shall not be transacted.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 4.  <I>Special Meetings.</I>  Except as otherwise provided by law, special meetings
of the stockholders may be called at any time by the Chairman of the Board, the President, or a majority of the Board
 of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 5.  <I>Business Transacted</I>-Special Meetings.  Business transacted at any special
meeting shall be confined to the purpose or purposes stated in the notice thereof.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 6.  <I>Notice of Meetings.</I>  Written notice of the annual meeting or of a special
meeting, stating the time, place, and purpose or purposes of the meeting, shall be given not less than ten (10) nor
more than sixty (60) days before the date of the meeting, either personally or by mail, to each stockholder of record
entitled to vote at such meeting.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 7.  <I>Quorum.</I>  The holders of a majority of the stock issued and outstanding and
entitled to vote thereat, represented in person or by proxy, shall constitute a quorum at all meetings of the stockholders
 for the transaction of business except as otherwise provided by statute or by the Restated Certificate of Incorporation.
If, however, such quorum shall not be present or represented at any meeting of the stockholders, the stockholders present
in person or represented by proxy shall have power to adjourn the meeting from time to time without notice other than
announcement at the meeting, until a quorum shall be present or represented. At such adjourned meeting at which a quorum
shall be present or represented, any business may be transacted which might have been transacted at the meeting as originally
notified.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 8.  <I>Voting.</I>  Whenever any action, other than the election of directors, is to be taken
 by vote of the stockholders, it shall be authorized by a majority of the votes cast at a meeting of stockholders at which a
quorum is present by the holders of shares entitled to vote thereon, unless a greater plurality is required by law or by the
Restated Certificate of Incorporation.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 9.  <I>Proxies.</I>  Any stockholder of record entitled to vote may be represented at any
annual or special meeting of the stockholders by a duly appointed proxy. A proxy may be given in any manner, and may take
 any form, allowed by applicable law provided that it is filed with, or communicated to, the Secretary of the meeting before
being voted.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 10.  <I>Consents to Corporate Action.</I>  (a)  <I>Action by Written Consent.</I>  Unless
otherwise provided in the Certificate of Incorporation, any action required or permitted to be taken at any annual or
special meeting of stockholders of the Corporation, subject to the provisions of subsections (b) and (c)&nbsp;of this
Section&nbsp;10, may be taken without a meeting upon the written consent (which shall set forth the action to be so taken)
 of less than all the stockholders entitled to cast at least the minimum number of votes which would be required to take such
 action at a meeting at which all stockholders entitled to vote thereon are present; <I>provided, however, </I>that prompt
notice of the taking of corporate action without a meeting and by less than unanimous written consent shall be given to
those stockholders who have not consented in writing.</P>
<P ALIGN="JUSTIFY"></P>
<OL START=2 TYPE="a">

<OL TYPE="a">

<I><P ALIGN="JUSTIFY"><LI>Determination of Record Date for Action by Written Consent.</I>  The record date for determining
stockholders entitled to express consent to corporate action in writing without a meeting shall be fixed by the Board of
 Directors of the Company. Any stockholder seeking to have the stockholders of the Corporation authorize or take corporate
 action by written consent without a meeting shall, by written notice to the Secretary of the Corporation, request the Board
 of Directors to fix a record date.  Upon  receipt  of  such  a  request,  the Secretary  shall,  as  promptly  as  practicable,
  call  a  special  meeting  of  the </LI></P></OL>
</OL>

<I><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
</I><P ALIGN="CENTER">IV-9</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">Board of Directors to be held as promptly as practicable. At such meeting, the Board of Directors shall
fix a record date within the limitations provided in Section&nbsp;14A:5-7 (or its successor provision) of the New Jersey
 Business Corporation Act. Notice of the record date shall be published in accordance with the rules and policies of any
stock exchange on which securities of the Company are then listed. Should the Board of Directors fail to fix a record date
as provided for in this paragraph&nbsp;(b), then the record date shall be the close of business on the day next preceding
the day on which notice of the meeting is given or, if no notice is given, the day next preceding the day on which the
 meeting is held.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;(c)  <I>Procedures for Written Consent.</I>  In the event of the delivery to the Company of a
 written consent or consents purporting to represent the requisite voting power to authorize or take corporate action
and/or related revocations, the Secretary of the Corporation shall provide for the safe-keeping of such consents and
revocations and shall engage nationally recognized independent inspectors of elections for the purpose of promptly
performing a ministerial review of the validity of the consents and revocations. No action by written consent without
 a meeting shall be effective until such inspectors have completed their review, have determined that the requisite
number of valid and unrevoked consents has been obtained to authorize the action specified in the consents, and have
certified such determination for entry into the records of the Corporation kept for the purpose of recording the
proceedings of meetings of stockholders.</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">ARTICLE IV</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Directors</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 1.  <I>Number and Term of Directors.</I>  The Board of Directors of the Corporation
shall consist of no fewer than three and no more than fourteen Directors and shall be divided into three classes,
namely, Classes&nbsp;I, II and III, with each class consisting of not fewer than one nor more than five Directors,
as the Board of Directors shall from time to time determine. In the absence of such determination by the Board of
Directors, the number shall be the number of Directors elected at the preceding Annual Meeting of Stockholders. At
each Annual Meeting of Stockholders, the successors to any class of Directors whose terms shall then expire shall be
elected to serve until the third Annual Meeting following their election and until their respective successors shall
 have been duly elected and qualified. Directors elected as hereinbefore provided may not be removed prior to the
expiration of their respective terms of office without cause. Directors need not be residents of the State of New
Jersey nor stockholders of the Corporation.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 2.  <I>Vacancies.</I>  Any vacancy occurring in the Board of Directors, including
any vacancy resulting from an increase in the number of Directors, may be filled until the next succeeding Annual
Meeting of Stockholders by the affirmative vote of a majority of the remaining Directors through less than a quorum
of the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 3.  <I>Notice of Stockholder Nominees.</I>  Only persons who are nominated in
accordance with the procedures set forth in this Section&nbsp;3 shall be eligible for election as Directors of
the Corporation. Nominations of persons for election to the Board of Directors of the Corporation may be made at
 an annual meeting of stockholders (a)&nbsp;by or at the direction of the Board of Directors or (b)&nbsp;by any
stockholder of the Corporation entitled to vote for the election of Directors at such annual meeting who complies
 with the procedures set forth in this Section&nbsp;3. All nominations by stockholders shall be made pursuant to
timely notice in proper written form to the Secretary of the Corporation. To be timely, a stockholder's notice
shall be delivered to or mailed and received at the principal executive offices of the Corporation not less than
90&nbsp;days nor more than 120&nbsp;days prior to the first anniversary of the preceding year's annual meeting;
provided, however, that in the event that the date of the annual meeting is more than 30 days before or more
than 60&nbsp;days after such anniversary date, notice by the stockholder to be timely must be so received not
 later than the close of business on the 10th day following the day on which public announcement of the date
of the annual meeting is first made. To be in proper written form, such stockholder's notice shall set forth
in writing (a)&nbsp;as to each person whom the stockholder proposes to nominate for election or re-election as
a Director, all information relating to such person that is required to be disclosed in solicitations of proxies
for election of directors, or is otherwise required, in each case pursuant to Regulation&nbsp;14A under the Securities
 Exchange Act of 1934, as amended, including, without limitation, such person's written consent to being named in the
proxy</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">IV-10</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY"> statement as a nominee and to serving as a Director if elected; and (b)&nbsp;as to the stockholder
 giving the notice (i)&nbsp;the name and address, as they appear on the Corporation's books, of such stockholder and
(ii)&nbsp;the class and number of shares of the Corporation which are beneficially owned by such stockholder. At the
request of the Board of Directors, any person nominated by the Board of Directors for election as a Director shall
furnish to the Secretary of the Corporation that information required to be set forth in a stockholder's notice of
nomination which pertains to the nominee. In the event that a stockholder seeks to nominate one or more Directors,
the Secretary shall appoint two inspectors, who shall not be affiliated with the Corporation, to determine whether
a stockholder has complied with this Section&nbsp;3. If the inspectors shall determine that a stockholder has not
complied with this Section&nbsp;3, the inspectors shall direct the chairman of the meeting to declare to the meeting
that a nomination was not made in accordance with the procedures prescribed by the By-Laws of the Corporation, and the
chairman shall so declare to the meeting and the defective nomination shall be disregarded.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 4.  <I>Duties and Powers.</I>  The Board of Directors shall have the control and
management of the affairs of the Corporation and shall exercise all such powers of the Corporation and do all
such lawful acts and things necessary or expedient in the control and management thereof as are not by statute
or by the Certificate of Incorporation or by these By-Laws directed or required to be exercised or done by the
stockholders. The Directors may adopt such rules and regulations for the conduct of their meetings and the management
 of the Corporation as they may deem proper, not inconsistent with the laws of the State of New Jersey.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 5.  <I>Meetings of the Board of Directors.</I>  Meetings of the Board of Directors shall
 be held at the office of the Corporation or at any other place within or without the State of New Jersey which the Chairman
 of the Board, or the President or a majority of the Board of Directors may from time to time designate. There shall be an annual
meeting of the Board of Directors held without notice upon the day of their election or as soon thereafter as convenient and such
 regular meetings, without notice, as the Board of Directors may by resolution establish. The Chairman of the Board or the President
 may call a special meeting of the Board of Directors and shall call a special meeting of the Board of Directors whenever requested in
writing by five (5)&nbsp;or more Directors so to do. Not less than two (2)&nbsp;days prior notice shall be given to each Director by
the Secretary of each special meeting of the Board of Directors. Such notice may be given by United States mail, electronic mail,
telecopy, overnight or same day courier or hand delivery or in person.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;A majority of the number of Directors shall constitute a quorum for the transaction of business, but the
Director or Directors present, if less than a quorum, may adjourn any meeting from time to time until such quorum be present.
 All questions coming before the Board shall be determined and decided by a majority vote of Directors present. Each Director
 shall be entitled to one (1) vote at all meetings of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 6.  <I>Compensation of Directors.</I>  Directors, as such, shall not receive any stated
salary for their services, but the Board may, from time to time, by resolution, fix the fees or compensation of the
Directors for services as such to the Corporation, including attendance at meetings of the Board of Directors or any
committee thereof. Nothing herein contained shall be construed to preclude any Director from serving the Corporation
in any other capacity and receiving compensation therefor.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 7.  <I>Executive Committee.</I>  The Board of Directors shall appoint an Executive
Committee from the Directors, consisting of not less than three (3) members, which Committee shall have and exercise
all of the authority of the Board of Directors in the management of the Corporation, except as otherwise required by
law. Vacancies in the membership of the Committee shall be filled by the Board of Directors at a regular or special
meeting of the Board of Directors. The Executive Committee shall keep regular Minutes of its proceedings and report
the same to the Board when required. A majority of the Committee shall be necessary to constitute a quorum, and in
every case the vote of the majority of the members present shall be necessary for the passage of any resolution.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">IV-11</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 8.  <I>Other Committees.</I>  The Board of Directors may appoint any other committee,
standing or special, from time to time, from among its own members or otherwise confer powers on such committee and
revoke such powers and terminate the existence of such committee at its pleasure. Each such committee shall keep Minutes
 of its proceedings and report same to the Board when required.</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">ARTICLE V</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Notices</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 1.  <I>Giving of Notice.</I>  Whenever, under the provision of the law or of the
Certificate of Incorporation or of these By-Laws, notice is required to be given to any Director or stockholder, it
 shall not be construed to mean personal notice, but such notice may be given in person or in writing, by mail, addressed
 to such Director or stockholder at his address as it appears on the records of the Corporation, with postage thereon prepaid.
 Notice to Directors may also be given by electronic mail, telecopy, overnight or same day courier or hand delivery. Notice given
 in person shall be deemed to be given when actually given; notice given by United States mail shall be deemed to be given at the
time when the same shall be deposited in the United States mail; notice given by electronic mail or telecopy shall be deemed to
be given at the time when the same shall be transmitted; and notice given by overnight or same day courier or hand delivery shall
be deemed to be given at the time when the same shall be delivered.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 2.  <I>Waiver.</I>  Whenever any notice whatever is required to be given under the provisions
of the statutes or under the provisions of the Certificate of Incorporation or of these By-Laws, a waiver thereof in writing
 signed by the person or persons entitled to such notice, whether before or after the time stated therein, shall be deemed
equivalent to the giving of such notice.</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">ARTICLE VI</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Officers</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 1.  <I>Election of Officers.</I>  The officers of the Corporation shall be a Chairman of the
Board; a Chief Executive Officer; a President; a Chief Financial Officer; one or more Group Presidents and/or Group Vice
Presidents; one or more Vice Presidents; a Secretary and a Treasurer. The Corporation may also have, at the discretion of
the Board, one or more Assistant Secretaries, one or more Assistant Treasurers, and such other officers, agents and employees
 as it shall deem necessary. Any two (2)&nbsp;of the aforesaid offices may be held by the same person. Every officer shall perform
such duties as the Board of Directors may from time to time designate.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;The Directors, immediately after each annual meeting of stockholders, shall appoint from their number a
Chairman of the Board, a Chief Executive Officer, and a President. At such meeting the Directors shall also choose one or more
 Vice Presidents, a Secretary and a Treasurer, none of whom need be a member of the Board.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;The Board of Directors may elect such other officers as it shall deem necessary, who shall hold their
offices for such terms and shall exercise such powers and perform such duties as shall be determined from time to time by the
 Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 2.  <I>Compensation.</I>  The salaries of all officers of the Corporation earning more than
$150,000 shall be fixed by the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 3.  <I>Term and Removal.</I>  The officers of the Corporation shall hold office for one
(1)&nbsp;year and until their successors are chosen and qualified in their stead. Any officer elected or appointed by
the Board of Directors may be removed at any time by the affirmative vote of a majority of the Directors. If the office
 of any officer becomes vacant for any reason, the vacancy shall be filled by the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">IV-12</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 4.  <I>Chairman of the Board.</I>  The Chairman of the Board shall be an Officer of the
 Corporation and shall preside at all meetings of the Board of Directors and stockholders. He shall assist the Board of
 Directors and other officers in the formulation of the policies of the Corporation and shall be available to other officers
for consultation and advice. He shall have such other powers and duties as may be from time to time prescribed by the Board
of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 5.  <I>Chief Executive Officer.</I>  The Chief Executive Officer shall be either the Chairman
of the Board or the President as designated by the Board of Directors. Under the direction of the Board of Directors, he shall
 have responsibility for the general direction of the Corporation's business, policies and affairs. The Chief Executive Officer
 shall be empowered at any time and from time to time to issue and promulgate rules, regulations and directives relating to the
conduct and the business and affairs of the Corporation. The Chief Executive Officer may hold such other offices of the
 Corporation as shall be designated by the Board of Directors. In the absence or disability of the Chairman of the Board,
 he shall preside over meetings of the Board of Directors and shareholders.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 6.  <I>President.</I>  The President shall be an officer and shall perform such duties as
assigned to him by the Board of Directors or Chairman of the Board. Subject to the above, he shall have the general powers
and duties of management usually vested in the office of President of the Corporation and shall have such other powers and
duties as may be prescribed by the Board of Directors or the By-Laws.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 7.  <I>Chief Financial Officer.</I>  The Chief Financial Officer shall be an officer,
elected and designated by the Board of Directors as Chief Financial Officer, who shall be responsible: (a)&nbsp;for
the receipt, custody and disbursement of all funds and securities of the Corporation; (b)&nbsp;to receive and give
receipts for monies due and payable to the Corporation from any source whatsoever and deposit all such monies in the
name of the Corporation in such banks, trust companies or other depositories as shall from time to time be selected;
(c)&nbsp;to disburse the funds of the Corporation as ordered by the Chief Executive Officer or as required in the
ordinary conduct of the business of the Corporation; (d)&nbsp;to render to the Chief Executive Officer or the Board
of Directors, upon request, an account of all transactions and on the financial condition of the Corporation; and
(e)&nbsp;in general, to perform all the duties incident to the office of Chief Financial Officer and such other duties
as from time to time may be assigned by the Chief Executive Officer, or the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 8.  <I>Group President/Group Vice President.</I>  The Corporation may have one or more
 Group Presidents and/or Group Vice Presidents. Such Group Presidents and/or Group Vice Presidents shall direct and
guide such operations, divisions or groups of the Corporation as shall be assigned to them by the President or the
Board of Directors, and shall assist the President in the development and formulation of overall company objectives,
 operating policies and plans, and shall have such additional powers and perform such additional duties as may be
assigned by the President or the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 9.  <I>Vice President.</I>  The Vice President, or if there shall be more than one
(1), shall have such powers and perform such duties as may be assigned by the President or Board of Directors. Vice
Presidents may be so designated by seniority and by function.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 10.  <I>Secretary.</I>  The Secretary shall attend all meetings of the Board of
Directors and of the stockholders, and shall record all votes and the Minutes of all proceedings in a book to be kept
 for that purpose. The Secretary shall give or cause to be given notice of all meetings of the stockholders and the
 Board of Directors and shall affix the seal of the Corporation to all certificates of stock, and to such other documents
as may require it, and shall have charge of the Corporation's seal, and the stock certificate book, and such other books
 and papers as the Board of Directors may direct, and shall cancel all surrendered stock certificates before issuing new
certificates, and shall preserve such cancelled certificates. The Secretary shall also perform such other duties as the
Board of Directors may from time to time prescribe.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 11.  <I>Assistant Secretary.</I>  An Assistant Secretary shall have and exercise all the
powers and duties of the Secretary in case of the Secretary's absence or inability to act and shall have such other powers
and perform such other duties as may be assigned to the Secretary by the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">IV-13</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&#9;SECTION 12.  <I>Treasurer.</I>  The Treasurer shall have the custody of the Corporate funds and
securities and shall deposit all monies and other valuable effects in the name and to credit of the Corporation in such
 depositories as may be authorized by the Board of Directors. The Treasurer shall disburse the funds of the Corporation
as may be ordered by the Board, taking proper vouchers for such disbursements and shall render to the Corporation an
account of all transactions and of the financial condition of the Corporation. The Treasurer shall perform such other
 duties and have such other powers as the Board, the Chief Executive Officer, the Chief Financial Officer, or the
officer to whom he shall report may from time to time prescribe.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 13.  <I>Assistant Treasurer.</I>  An Assistant Treasurer shall have and exercise all
the powers and duties of the Treasurer in case of the Treasurer's absence or inability to act and shall have such
other powers and perform such other duties as may be assigned by the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 14.  <I>Controller.</I>  The Controller shall be the chief accounting officer of
the Corporation and shall keep or cause to be kept correct records of the business and transactions of the
Corporation and shall, upon request, at all reasonable times exhibit or cause to be exhibited such records
 at the place where such records are kept. He shall perform such other duties as from time to time may be
assigned to him by the Chief Executive Officer, the President, the Chief Financial Officer or the officer
 to whom he shall report.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 15.  <I>General Counsel.</I>  The General Counsel shall be the chief legal
 officer of the Corporation and shall have, subject to the control of the Board of Directors and the Chief
Executive Officer, general and active supervision and direction over the legal affairs of the Corporation.
 He shall have such other powers and perform such other duties as may be assigned to him by the Board of Directors,
the Chief Executive Officer, or the officer to whom he shall report.</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">ARTICLE VII</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Certificates of Stock</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 1.  <I>Form.</I>  The certificates of stock of the Corporation shall be numbered
 and entered in the books of the Corporation as they are issued. They shall exhibit the holder's name and the
 number of shares and shall be signed by the Chairman of the Board or the President or a Vice President and the
Treasurer or an Assistant Treasurer or the Secretary or an Assistant Secretary, and shall bear the Corporate seal.
 Such seal may be a facsimile, engraved or printed. Where certificates are manually signed by a Transfer Agent or
Registrar who is not an officer or employee of the Corporation, all other signatures on the certificates may be facsimile.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 2.  <I>Transfer of Stock.</I>  Upon surrender to the Corporation or the Transfer
 Agent of the Corporation of a certificate of stock duly endorsed or accompanied by proper evidence of succession,
assignment or authority to transfer, it shall be the duty of the Corporation to issue a new certificate to the person
 entitled thereto and cancel the old certificates; every such transfer of stock shall be entered on the stock books of the Corporation.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 3.  <I>Holders of Record</I>  The Corporation shall be entitled to treat the holder of
record of any share or shares of stock as the holder in fact thereof, and, accordingly, shall not be bound to recognize
any equitable or other claims to or interest in such share on the part of any other person whether or not it shall have
express or other notice thereof, except as expressly provided by the laws of New Jersey.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">IV-14</P>
<B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">ARTICLE VIII</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">General Provisions</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 1.  <I>Stockholders' Record Date.</I>  Except as otherwise provided in these By-Laws, in
order that the Corporation may determine the stockholders entitled to notice of or to vote at any meeting of stockholders
 or any adjournment thereof, or entitled to receive payment of any dividend or other distribution or allotment of any rights,
 or entitled to exercise any rights in respect of any change, conversion or exchange of stock or for the purpose of any other lawful
action, the Board of Directors may fix, in advance, a record date, which shall not be more than sixty (60)&nbsp;nor less than ten (10) days
 before the day of such meeting, nor more than sixty (60) days prior to any other action. A determination of stockholders of record entitled to
 notice of or to vote at a meeting of stockholders shall apply to any adjournment of the meeting; provided, however, that the Board of Directors
 may fix a new record date for the adjourned meeting.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 2.  <I>Dividends.</I>  Dividends upon the capital stock of the Corporation, subject to any provisions of the
Certificate of Incorporation relating thereto, may be declared by the Board of Directors at any regular or special meeting, pursuant to law.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;Before payment of any dividend, there may be set aside out of the net profits of the Corporation available for dividends
such sum or sums as the Directors from time to time in their absolute discretion think proper as a reserve fund to meet contingencies, or for
equalizing dividends, or for repairing or maintaining any property of the Corporation, or for such other purpose as the Directors shall think conducive
 to the interests of the Corporation, and the Directors may modify or abolish any such reserve in the manner in which it was created.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 3.  <I>Checks.  </I>All checks or demands for money and notes of the Corporation shall be signed by such officer or
 officers or such other person or persons as the Board of Directors may from time to time designate.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;SECTION 4.  <I>Fiscal Year.  </I>The fiscal year of the Corporation shall be fixed by resolution of the Board of Directors.</P>
<P ALIGN="JUSTIFY"></P>
<B><P ALIGN="CENTER">ARTICLE IX</P>
<P ALIGN="CENTER"></P>
<P ALIGN="CENTER">Amendments</P>
</B><P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&#9;These By-Laws may be altered, amended, or repealed or new By-Laws may be adopted by the affirmative vote of a majority of the
 Board of Directors at any regular or special meeting of the Board, subject to any provisions in the Certificate of Incorporation or the statutes,
reserving to the stockholders the power to adopt, amend, or repeal By-Laws, provided, however, that By-Laws made by the Board may be altered or
repealed and new By-Laws made by the stockholders. The stockholders may prescribe that any By-Law made by them shall not be altered or repealed by the Board.</P>
<P ALIGN="JUSTIFY"></P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">IV-15</P></FONT></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>3
<TEXT>

<HTML>
<HEAD>
<TITLE>Exhbt10z</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="Garamond"><P>Exhibit 10z*</P>
<B><U><P ALIGN="CENTER">C. R. Bard, Inc. Management Stock Purchase Plan</P>
<P ALIGN="CENTER">As Amended and Restated December 8, 1999</P>
</U><P>Article 1.&#9;Establishment and Objectives</P>
<OL>
<OL>

<P ALIGN="JUSTIFY"><LI>Establishment of the Plan</B>. C. R. Bard, Inc., a
New Jersey corporation, hereby estabhishes, effective January 1, 1998, the
C. R. Bard, Inc. Management Stock Purchase Plan (the "Plan"), as set forth
in this document. The Plan provides a mechanism for deferral of the receipt
 of certain bonuses through mandatory and voluntary purchases of restricted
stock.</LI></P>
<B><P ALIGN="JUSTIFY"><LI>Objectives of the Plan</B>. The objectives of the
Plan are to link the interests of Participants to those of the Company's
 stockholders; to allow Participants to share in the success of the Company;
 and to assist in fulfilling the Company stock ownership requirements of
 Participants.</LI></P></OL>
</OL>

<B><P>Article 2.&#9;Definitions</P>
</B><P ALIGN="JUSTIFY">&#9;Whenever used in the Plan, the following terms shall have the meanings set forth below, and when the meaning is intended,
the initial letter of the word shall be capitalized:</P>
<P ALIGN="JUSTIFY">&#9;<B>"Applicable Fair Market Value"</B> means the lower of (a) the Fair Market Value on the first business day in July of the
calendar year preceding the date the bonus otherwise would have been payable; or (b) the Fair Market Value on the date the bonus otherwise would have been payable.</P>
<P ALIGN="JUSTIFY">&#9;<B>"Board"</B> means the Board of Directors of the Company.</P>
<P ALIGN="JUSTIFY">&#9;<B>"Bonus Plan"</B> means the Executive Bonus Plan, the Executive Inventive Plan, or any other bonus plan or arrangement of
the Company designated by the Committee.</P>
<P ALIGN="JUSTIFY">&#9;<B>"Change of Control"</B> of the Company means a
change of control of the nature that would be required to be reported in
response to item 1(a) of the Current Report on Form 8-K as in effect on the
Effective Date pursuant to Section 13 or 15(d) of the Exchange Act,
 provided that, without limitation, a "Change of Control" shall be deemed
to have occurred if (i) any person shall become the beneficial owner,
as those terms are defined herein, of capital stock of the Company, the
voting power of which constitutes 20% or more of the general voting power
of all of the Company's outstanding capital stock or (ii) individuals who,
as of the Effective Date, constitute the Board (the "Incumbent Board")
cease for any reasons to consitute at least a majority of the Board.</P>
<P ALIGN="JUSTIFY">&#9;<B>"Premium Shares"</B> means Shares credited to a
Participant's Deferral Account which are initially subject to forfeiture
 as provided in Section 6.2 or Section 6.3.</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="CENTER">IV-16</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P ALIGN="JUSTIFY">&#9;<B>"Retirement"</B> means normal or early retirement
under the terms of a pension plan of the Company or voluntary termination
of employment, provided that in each case the Company must have given its
prior consent to treat the person's termination of employment as a
Retirement.</P>
<P ALIGN="JUSTIFY">&#9;<B>"Shares"</B> means the shares of common stock,
$.25 per value, of the Company.</P>
<P ALIGN="JUSTIFY">&#9;<B>"Subsidiary"</B> means any corporation, other
than the Company, in an unbroken chain of corporations beginning with the
 Company if each of the corporations other than the last corporation in the
unbroken chain owns stock possessing 50% or more of the total combined
 voting power of all classes of stock in one of the other corporations in
such chain.</P>
<B><P>Article 3.&#9;Administration</P>
<OL>
<OL>

<P ALIGN="JUSTIFY"><LI>The Committee</B>. The Plan shall be administered by the Committee. The Committee (unless otherwise determined by the Board)
shall satisfy the "nonemployee director" requirements of Rule 16b-3 under the Exchange Act and the regulations thereunder and the "outside director"
 provisions of Code Section 162(m, or any successor regulations or provisions. The members of the Committee shall be appointed from time to time by,
 and shall serve at the discretion of, the Board. The Committee shall act by a majority of its members at the time in office and eligible to vote on
any particular matter, and such action may be taken either by a vote at a
meeting or in writing without a meeting.</LI></P>
<B><P ALIGN="JUSTIFY"><LI>Authority of the Committee</B>. Except as limited
by law and subject to the provisions herein, the Committee shall have full
 power to construe and interpret the Plan and any agreement or instrument
entered into under the Plan, and establish, amend or waive rules and
regulations for the Plan's administration. Further, the Committee shall make
all other determinations which may be necessary or advisable for
the administration of the Plan. The Committee may delegate its authority to
the extent permitted by law and sonsistant with Section 3.1.
 (Without limiting the generality of the foregoing, in the event of a
subdivision or consolidation of outstanding Shares or the payment of
 a stock dividend or other change affecting the Shares, such adjustments
shall be made as shall be deemed equitable by the Committee to give
proper effect to such event).</LI></P>
<B><P ALIGN="JUSTIFY"><LI>Decisions Binding</B>. All determinations and decisions made by the Committee pursuant to the provisions of the Plan
shall be final, conclusive and binding on all persons, including the Company, its stockholders, the Board, all Subsidiaries, employees, participants
 and their estates and beneficiaries.</LI></P></OL>
</OL>

<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-17</P></FONT></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>4
<TEXT>

<HTML>
<HEAD>
<TITLE>Exhibit 10aa*</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="Garamond"><P>Exhibit 10aa*</P>
<B><P ALIGN="CENTER">1998 EMPLOYEE STOCK PURCHASE PLAN</P>
<P ALIGN="CENTER">OF</P>
<P ALIGN="CENTER">C. R. BARD, INC.,</P>
<P ALIGN="CENTER">AS AMENDED AND RESTATED</P>
</B><P>The 1998 Employee Stock Purchase Plan of C. R. Bard, Inc., as Amended and Restated, provides Eligible Employees of C. R. Bard, Inc., a New Jersey corporation
(the "Company"), and its Subsidiaries an opportunity to purchase shares of Common Stock of the Company on the terms and conditions set forth below.</P>
<P>1. <U>Definitions</P><DIR>
<DIR>

</U><P>(a) Business Day: any day the New York Stock Exchange is open for business.</P>
<P>(b) Code: the Internal Revenue Code of 1986, as amended.</P>
<P>(c) Common Stock: the Company's Common Stock, par value $.25 per share.</P>
<P>(d) Compensation: with respect to a Participant, the portion of the Participant's basic pay, overtime pay and vacation and holiday pay paid to the Participant during
the applicable payroll period.</P>
<P>(e)&#9;Delayed Purchase Date: has the meaning specified in Section 8(b).&#9;</P>
<P>(f) Eligible Employee: an employee who is eligible to participate in the Plan pursuant to Section 3.</P>
<P>(g) Fair Market Value: the mean between the high and low sales price of the Common Stock on the subject day as reported on the New York Stock Exchange--Composite
Transactions Tape or, if no sale of the Common Stock shall have occurred on the New York Stock Exchange on that day, on the next preceding day on which there is a sale.
 If the Common Stock is not traded on the New York Stock Exchange, the Fair Market Value shall be the amount that is reasonably determined by the Plan Administrator.</P>
<P>(h) Grant Date: each January 1 and July 1.</P>
<P>(i) Option: an option to purchase shares of Common Stock under the Plan, pursuant to the terms and conditions hereof.</P>
<P>(j) Participant: an Eligible Employee who is participating in the Plan pursuant to Section 4.</P>
<P>(k) Plan: 1998 Employee Stock Purchase Plan of C. R. Bard, Inc., as Amended and Restated, as further amended from time to time.</P>
<P>(l) Plan Account: an account maintained by the Company or its designated recordkeeper for each Participant to which the Participant's payroll deductions are credited,
 against which funds used to purchase shares of Common Stock are charged and to which shares of Common Stock purchased are credited.</P>
<P>(m) Plan Administrator: the Retirement Committee under the Retirement Plan, or such other person or persons, including a committee, as may be appointed by the Board
of Directors of the Company to administer the Plan. The Board of Directors of the Company may at any time remove or replace the Plan Administrator.</P>
<P>&nbsp;</P></DIR>
</DIR>

<P ALIGN="CENTER">IV-18</P><DIR>
<DIR>

<P>(n) Purchase Date: except as provided in Section 16, each June 30 and December 31 (or the following Business Day if such date is not a Business Day).</P>
<P>(o) Purchase Price: unless the Plan Administrator determines before a Grant Date that a higher or lower price that complies with Code Section 423 shall apply, the
Purchase Price of the shares of Common Stock which are to be sold under the Plan on the Purchase Date (and on the related Delayed Purchase Date) next following such
 Grant Date shall be the lesser of 85% of the Fair Market Value of Common Stock on such Grant Date and 85% of the Fair Market Value of a share of Common Stock on such
 Purchase Date.</P>
<P>(p) Retirement Plan: the Employees' Retirement Plan of C. R. Bard, Inc., as amended.</P>
<P>(q) Subsidiary: any corporation, other than the Company, in an unbroken chain of corporations beginning with the Company if, at the time of the granting of the
 Option, each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting power of all
 classes of stock in one of the other corporations in such chain.</P></DIR>
</DIR>

<P>2. <U>Stock Subject to the Plan</U>. Subject to Section 13, the aggregate number of shares of Common Stock which may be sold under the Plan is 500,000. The Company
 may make open-market purchases, sell treasury shares or issue authorized but unissued shares of Common Stock to provide shares of Common Stock for purchase under the Plan.</P>
<P>3. <U>Eligible Employees</U>. An "Eligible Employee" means each employee of the Company or any domestic Subsidiary, and each</P>
<P>employee of a foreign Subsidiary to which the Plan is extended by the Plan Administrator, except:</P><DIR>
<DIR>

<P>(a) an employee whose customary employment is fewer than 20 hours or less per week; or</P>
<P>(b) an employee whose customary employment is for fewer than five months in any calendar year.</P></DIR>
</DIR>

<P>4. <U>Participation in the Plan</U>.</P><DIR>
<DIR>

<P>(a) An Eligible Employee may elect to participate in the Plan by completing and filing with the Company or its designated recordkeeper an election form or by
making such election in such other manner as the Plan Administrator may determine, which other manner will be communicated to Eligible Employees. Any such election
 will authorize payroll deductions from the employee's Compensation. Such deductions shall commence on the first Grant Date thereafter as elected by the Employee,
 and shall continue until the Employee terminates participation in the Plan or the Plan is terminated. An Eligible Employee may participate in the Plan only
through payroll deductions. Other contributions will not be accepted.</P>
<P>(b) Notwithstanding the foregoing, an Eligible Employee shall not be granted an Option on any Grant Date if such employee, immediately after the Option is
granted, owns stock possessing 5% or more of the total combined voting power or value of all classes of stock of the Company or any Subsidiary. For purposes
of this paragraph, the rules of Code Section 424(d) shall apply in determining the stock ownership of an individual, and stock which an employee may purchase
under outstanding options shall be treated as stock owned by the employee.</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-19</P></DIR>
</DIR>

<P>5. <U>Payroll Deductions</U>. Payroll deductions shall be made from the Compensation paid to each Participant for each payroll period in such whole percentage
 from 1% to 10%, as the Participant shall authorize in such Participant's election form. No Eligible Employee may be granted an Option which permits such Eligible
 Employee to purchase Common Stock under the Plan, and any other stock purchase plan of the Company or any Subsidiary that is qualified under Section 423 of the
Code, to accrue at a rate which exceeds $25,000 of Fair Market Value of such stock (determined at the time such Option is granted) for each calendar year in which
 the Option is outstanding at any time.</P>
<P>6. <U>Changes in Payroll Deductions</U>. Subject to the minimum and maximum deductions set forth above, a Participant may change the amount of such Participant's
 payroll deductions as of the next Grant Date by filing a new election form with the Company or its designated recordkeeper (or by making such election in such other
 manner as the Plan Administrator may determine, which other manner will be communicated to Eligible Employees) no later than ten Business Days in advance of the next
 Grant Date. The change shall be effective until revoked in writing.</P>
<P>7. <U>Termination of Participation in Plan</U>. A Participant may, at any time and for any reason, voluntarily terminate participation in the Plan by written
notification of withdrawal delivered to the Plan Administrator. Such Participant's payroll deductions under the Plan shall cease as soon as practicable following
delivery of such notice. A Participant's participation in the Plan shall be terminated upon termination of such Participant's employment with the Company and its
 Subsidiaries for any reason. If the former Participant remains employed by the Company or any of its Subsidiaries after termination of participation in the Plan,
 any payroll deductions credited to such Participant's Plan Account shall be used to purchase shares of Common Stock on the next Purchase Date or Delayed Purchase
Date (as defined below), as the case may be. If the former Participant is no longer employed by the Company or any of its Subsidiaries after termination of
participation in the Plan, any payroll deductions credited to such Participant's Plan Account shall be paid to such Participant in cash as soon as practicable
 following termination of employment. An Eligible Employee whose participation in the Plan is terminated may rejoin the Plan by making an election to participate
 in accordance with Section&nbsp;6.</P>
<P>8. <U>Purchase of Shares</U>.</P>
<P>(a) On each Grant Date, each Participant shall be deemed to have been granted an Option.</P>
<P>(b) On each Purchase Date, each Participant shall be deemed, without any further action, to have purchased that number of shares of Common Stock determined
by dividing the Purchase Price into the cash balance in the Participant's Plan Account on the Purchase Date; provided, that in respect of any Purchase Date
(other than a date deemed to be a Purchase Date pursuant to Section 16) any Participant may elect (a "Deferral Election") by written notification delivered
to the Company or its designated recordkeeper (or in such other manner as the Plan Administrator may determine, which other manner will be communicated to
Eligible Employees) not less than 10 days prior to such Purchase Date (which election shall remain in effect until revoked in writing) to delay such purchase
 to the immediately following January 1, in the case of a Purchase Date on June 30, or July 1, in the case of a Purchase Date on December 31 (the "Delayed
Purchase Date"), on which date such Participant shall be deemed, without any further action, to have purchased that number of shares of Common Stock
determined by dividing the Purchase Price (determined as of the Purchase Date with respect to which the Deferral Election was made (i.e., the second
preceding Purchase Date)) into the cash balance in the Participant's Plan Account as of such Purchase Date; provided, further, that each Participant
 employed by a Subsidiary organized in Germany, the United Kingdom or Italy or any other country designated from time to time by the Plan Administrator
 (which designation the Plan Administrator shall promptly make known to affected Eligible Employees) shall be deemed to have made such election unless
 such Participant elects to the contrary by written notification delivered to the Company or its designated recordkeeper (or in such other manner as the
 Plan Administrator may determine, which other manner will be communicated to Eligible Employees) not less than 10 days prior to such Purchase Date (which
election shall remain in effect until revoked in writing).</P>
<P ALIGN="CENTER">IV-20</P>
<P>(c) As soon as practicable after each Purchase Date, a statement shall be delivered to each Participant who has not made a Deferral Election which shall
 include (i) the number of shares of Common Stock purchased on the Purchase Date on behalf of such Participant under the Plan, (ii) the purchase price per
share applicable to such Purchase Date and (iii) the total amount of cash transferred to the Participant's Plan Account since the immediately preceding Grant
Date pursuant to Section 5. As soon as practicable after each Purchase Date, a statement shall be delivered to each Participant who has made a Deferral Election
 which shall include (i) the total amount of cash transferred to the Participant's Plan Account since the immediately preceding Grant Date pursuant to Section 5
and (ii) the purchase price per share applicable to such Purchase Date. As soon as practicable after each Delayed Purchase Date, a statement shall be delivered
to each Participant who has made a Deferral Election which shall include (i) the number of shares of Common Stock purchased on the Delayed Purchase Date on behalf
 of such Participant under the Plan, (ii) the Purchase Price per share applicable to such Delayed Purchase Date and (iii) the cash balance in the Participant's
Plan Account as of the second preceding Purchase Date.</P>
<P>(d) A stock certificate for whole shares of Common Stock in a Plan Account shall be issued and a cash payment for any fraction of a share of Common Stock in
 a Plan Account will be made upon request at any time after such shares have been held in such Participant's Plan Account for a period of six months; provided,
that a stock certificate for whole shares of Common Stock in a Participant's Plan Account which were purchased on a Delayed Purchase Date shall be issued and a
cash payment for any fraction of a share of Common Stock in a Plan Account which was purchased on a Delayed Purchase Date will be made upon request of the Participant
 at any time. Notwithstanding the preceding sentence, if the Participant's employment with the Company and its Subsidiaries terminates, a stock certificate
for whole shares and a cash payment for fractional shares of Common Stock in such Participant's Plan Account shall be issued or made as soon as administratively
 feasible thereafter. Stock certificates under the Plan shall be issued, at the election of the Participant, in such Participant's name or in such Participant's
name and the name of another person as joint tenants in common. </P>
<P>9. <U>Rights as a Shareholder</U>. As of the Purchase Date or Delayed Purchase Date, as the case may be, a Participant shall be treated as record owner of
such Participant's shares purchased pursuant to the Plan.</P>
<P>10. <U>Rights Not Transferable</U>. Rights under the Plan are not transferable by a Participant other than by will or the laws of descent and distribution,
and are exercisable during the Participant's lifetime only by the Participant or by the Participant's guardian or legal representative. No rights or payroll
deductions of a Participant shall be subject to execution, attachment, levy garnishment or similar process.</P>
<P>11. <U>Sale of Purchased Stock</U>. An Eligible Employee must advise C. R. Bard, Inc. promptly if the Eligible Employee disposes of any shares of Common
 Stock purchased by the Eligible Employee under the Plan if such disposition shall have occurred within two years after the Grant Date immediately preceding
the Eligible Employee's purchase of such shares.</P>
<P>12. <U>Application of Funds</U>. All funds of Participants received or held by the Company under the Plan before purchase of the shares of Common Stock
shall be held by the Company without liability for interest or other increment.</P>
<P>13. <U>Adjustments in Case of Changes Affecting Shares</U>. In the event of a subdivision or consolidation of outstanding shares of Common Stock, or the
 payment of a stock dividend, the number of shares approved for the Plan shall be increased or decreased proportionately, and such other adjustment shall
be made as may be deemed equitable by the Plan Administrator. In the event of any other change affecting the Common Stock, such adjustment shall be made as
 shall be deemed equitable by the Plan Administrator to give proper effect to such event.&nbsp;</P>
<P ALIGN="CENTER">IV-21</P>
<P>14. <U>Administration of the Plan</U>. The Plan shall be administered by the Plan Administrator. The Plan Administrator shall have authority to make rules
and regulations for the administration of the Plan and its interpretations, and decisions with regard to the Plan and such rules and regulations shall be final
 and conclusive. It is intended that the Plan shall at all, times meet the requirements of Code Section 423, if applicable, and the Plan Administrator shall,
 to the extent possible, interpret the provision of the Plan so as to carry out such intent.</P>
<P>&nbsp;</P>
<P>15. <U>Amendments to the Plan</U>. The Plan Administrator may, at any time, or from time to time, amend or modify the Plan; provided, however, that no
amendment shall be made increasing or decreasing the number of shares authorized for the Plan (other than as provided in Section 13 or 16), and that no
amendment shall be made which would cause the Plan to fail to meet the applicable requirements of Code Section 423.</P>
<P>&nbsp;</P>
<P>16. <U>Termination of Plan</U>. The Plan shall terminate upon the earlier of (a) the termination of the Plan by the Board of Directors of the Company
 as specified below or (b) the date no more shares remain to be purchased under the Plan. The Board of Directors of the Company may terminate the Plan as
 of any date, and the date of termination shall be deemed a Purchase Date. If on such Purchase Date or at any other time Participants in the aggregate have
 Options to purchase more shares of Common Stock than are available for purchase under the Plan, each Participant shall be eligible to purchase a reduced
number of shares of Common Stock on a pro rata basis, and any excess payroll deductions shall be returned to Participants, all as provided by rules and
regulations adopted by the Plan Administrator.</P>
<P>&nbsp;</P>
<P>17. <U>Costs</U>. All costs and expenses incurred in administering the Plan shall be paid by the Company. Any costs or expenses of selling shares
of Common Stock acquired pursuant to the Plan shall be borne by the holder thereof.</P>
<P>&nbsp;</P>
<P>18. <U>Governmental Regulations</U>. The Company's obligation to sell and deliver Common Stock pursuant to the Plan is subject to the approval of any
governmental authority required in connection with the authorization, issuance or sale of such stock.</P>
<P>&nbsp;</P>
<P>19. <U>Applicable Law</U>. The Plan shall be interpreted under the laws of the United States of America and, to the extent not inconsistent therewith,
by the laws of the State of New Jersey. The Plan is not to be subject to the Employee Retirement Income Security Act of 1974, as amended, but is intended
to comply with Code Section 423. Any provisions required to be set forth in the Plan by such Code section are hereby included as fully as if set forth in
the Plan in full.</P>
<P>&nbsp;</P>
<P>20. <U>Effect on Employment</U>. The provisions of the Plan shall not affect the right of the Company or any Subsidiary or any Participant to terminate
the Participant's employment with the Company or any Subsidiary.</P>
<P>&nbsp;</P>
<P>21. <U>Withholding</U>. The Company reserves the right to withhold from stock or cash distributed to a Participant any amounts which it is required by
law to withhold.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-22</P>
<P>22. <U>Sale of Company</U>. In the event of a proposed sale of all or substantially all of the assets of the Company or a merger of the Company with or
 into another corporation, the Company shall require that each outstanding Option be assumed or an equivalent right to purchase stock of the successor or
purchaser corporation be substituted by the successor or purchaser corporation, unless the Plan is terminated.</P>
<P>23. <U>Effective Date</U>. The Plan shall become effective July 1, 1998, provided that the stockholders of the Company approve it within 12 months after
the date the Plan was adopted by the Board of Directors of the Company.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-23</P></FONT></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10
<SEQUENCE>5
<TEXT>

<HTML>
<HEAD>
<TITLE>Retirement Plan for Outside Directors of</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="Garamond"><P>Exhibit 10ab*</P>
<U><P ALIGN="CENTER">Retirement Plan for Outside Directors of</P>
<P ALIGN="CENTER">C. R. Bard, Inc.</P>
<P ALIGN="CENTER">(As Amended and Restated Effective as of September 9, 1992)</P>
<OL>

<P ALIGN="JUSTIFY"><LI>Purpose</U>. By providing Outside Directors with the opportunity for retirement income, C. R. Bard, Inc. (the Corporation)
intends to enhance the Corporation's ability to attract and retain the services of experienced Outside Directors and to have available their continuing
counsel following retirement from the Board of Directors. The Plan is intended to be an unfunded plan maintained for the purpose of providing deferred
compensation for Outside Directors (who are not employees of the Corporation) and as such is exempt from the Employee Retirement Income Security Act of
1974. The Plan is hereby amended and completely restated in this instrument effective as of September 9, 1992.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Definitions</U>. Except as otherwise specified, or as the context may otherwise require, the following have the meanings indicated
 below for all Plan purposes.</LI></P>
<OL TYPE="a">

<U><P ALIGN="JUSTIFY"><LI>Annual Retainer</U> is the annual amount, exclusive of any Meeting Fees, received by an Outside Director as may from time to time
 be set by the Board of Directors.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Change of Control</U> shall mean and be deemed to occur if a change of control of the nature that would be required to be
 reported in response to Item 1(a) of the Current Report on Form 8-K as in effect on the date hereof, September 9, 1992, pursuant to Section 13 or
 15(d) of the Securities Exchange Act of 1934 (the "Exchange Act"), provided that, without limitation, a "Change of Control" shall be deemed to have
 occurred if (1) the beneficial ownership at any time hereafter by any "person," as defined herein, of capital stock of the Corporation, the voting
 power of which constitutes 20% or more of the general voting power of all of the Corporation's outstanding capital or (2) individuals who, as of the
 date hereof, September 9, 1992, constitute the Board of Directors of the Corporation (the "Board" generally and as of the date hereof the "Incumbent
Board") cease for any reason to constitute at least a majority of the Board, provided that any person becoming a director subsequent to the date hereof
 whose election or nomination for election by the Corporation's shareholders was approved by a vote of at least three-quarters of the directors comprising
 the Incumbent Board (other than an election or nomination of an individual whose initial assumption of office is in connection with an actual or threatened
election contest relating to the election of the directors of the Corporation, as such terms are used in Rule 14a-11 of Regulation 14A promulgated under
the Exchange Act) shall be, for purposes of this Plan, considered as though such person were a member of the Incumbent Board. No sale to underwriters or
 private placement of its capital stock by the Corporation, nor any acquisition by the Corporation, through merger, purchase of assets or otherwise,
effected in whole or in part by issuance or reissuance of shares of its capital stock, shall constitute a Change of Control. For purposes of this
definition of "Change of Control," the following definitions and rules shall be applicable:</LI></P>
<OL TYPE="i">

<LI>The term "person" shall mean any individual, group, corporation or other entity.</LI>
<P ALIGN="JUSTIFY"><LI>Any person shall be deemed to be the beneficial owner of any shares of capital stock of the Corporation:</LI></P>
<P ALIGN="CENTER">IV-24</P>
<OL TYPE="A">

<LI>which that person owns directly, whether or not of record, or</LI>
<P ALIGN="JUSTIFY"><LI>which that person has the right to acquire pursuant to any agreement or understanding or upon exercise of conversion rights,
warrants, or options, or otherwise, or</LI></P>
<P ALIGN="JUSTIFY"><LI>which are beneficially owned, directly or indirectly (including shares deemed owned through application of clause (B) above),
by an "affiliate" or "associate" (as defined in the rules of the Securities and Exchange Commission under the Securities Act of 1933) of that person
or</LI></P>
<P ALIGN="JUSTIFY"><LI>which are beneficially owned, directly or indirectly (including shares deemed owned through application of clause (B) above),
 by any other person with which that person or his "affiliate" or "associate" (defined as aforesaid) has any agreement, arrangement or understanding
for the purpose of acquiring, holding, voting or disposing of capital stock of the Corporation.</LI></P></OL>

<P ALIGN="JUSTIFY"><LI>The outstanding shares of capital stock of the Corporation shall include shares deemed owned through application of clauses
(ii)(B), (C) and (D), above, but shall not include any other shares which may be issuable pursuant to any agreement or upon exercise of conversion
rights, warrants or options, or otherwise, but which are not actually outstanding.</LI></P>
<P ALIGN="JUSTIFY"><LI>Shares of capital stock, if any, held by The Chase Manhattan Bank N.A. under the Indenture and the Escrow Agreement dated as
 of November 1, 1971 between International Paper Company and said Bank shall not be deemed owned by International Paper Company or by said Bank for
 purposes of this Plan, so long as they are held by said Bank under said Escrow Agreement, but said shares shall be deemed outstanding for the purpose
 of determining the aggregate number of outstanding shares of capital stock of the Corporation.</LI></P></OL>

<U><LI>Effective Date of the Plan</U> means January 1, 1984.</LI>
<U><P ALIGN="JUSTIFY"><LI>Meeting Fee</U> is the fee paid to an Outside Director for attendance at each meeting of the Board of Directors and each
meeting of any Committee of the Board of Directors, but shall not include the additional fee paid to a Committee Chairman.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Outside Director</U> means a member of the Board of Directors of the Corporation who is not also an employee of the
Corporation.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Plan</U> is the "Retirement Plan for Outside Directors of C. R. Bard, Inc." The Plan shall be administered by the
Policy, Procedures and Organization Committee of the Board of Directors.</LI></P>
<U><P>&nbsp;</P>
</U><P ALIGN="CENTER">IV-25</P>
<U><P>&nbsp;</P>
<P ALIGN="JUSTIFY"><LI>Retirement Income</U> shall be an amount equal to the amount of the Annual Retainer received by an Outside Director at
 the time his Service ceases, together with 12 times the amount of the Meeting Fee received by the outside Director at the time his service ceases.
In the event that the Outside Director's Service shall cease prior to July 1 of any year, then for purposes of computing the Annual Retainer and Meeting
Fee, such amount shall be deemed to be the amount of the Annual Retainer or Meeting Fee which was in effect on July 1 of the year in which such Outside
Director's Service shall have ceased.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Service</U> is the number of years that the Outside Director has served on the Board at retirement. Effective as of September
 9, 1992, in the event that an Outside Director's Service shall include a partial year, such partial year shall be rounded up to a full year.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Vested Benefits</U> means the amount of Retirement Income which an Outside Director shall have become entitled to by reason of
 his Service.</LI></P></OL>

<U><LI>Eligibility</U>.</LI>
<OL TYPE="a">

<P ALIGN="JUSTIFY"><LI>All Outside Directors of the Corporation who serve on the Board of the Corporation on or after the Effective Date of the Plan,
 and other retired Outside Directors, are eligible to receive Retirement Income subject to the terms of the Plan contained herein, except that no
Outside Director shall be entitled to participate in or to receive any amounts pursuant to this Plan if such Outside Director is receiving benefits
under the Employees' Retirement Plan of C. R. Bard, Inc.</LI></P>
<P ALIGN="JUSTIFY"><LI>If a Change of Control occurs prior to the date an Outside Director is eligible to receive Retirement Income, then for purposes
of this Plan, the amount of retirement income which the Outside Director would have been entitled to receive had he retired on the date of the Change of
 Control shall be irrevocably vested in the Outside Director, and he shall be entitled to receive same together with any additional amounts earned since
the date of the Change of Control in accordance with the provision of this Plan.</LI></P></OL>

<U><P ALIGN="JUSTIFY"><LI>Amount of Retirement Income</U>. For an Outside Director who retires on or after September 9, 1992, the annual amount of
Retirement Income shall be the Percentage of Retirement Income in accordance with the schedule below for the period specified in section 5. hereinafter.</LI></P>
<U><P>Service at Termination</U>&#9;<U>Percentage of Retirement Income</P>
</U><P>Less than 5 years&#9;&#9; &#9;               0%</P>
<P>5 years or more&#9;&#9;&#9;&#9;100%</P>
<U><P ALIGN="JUSTIFY"><LI>Commencement and Duration of Retirement Income</U>. Retirement Income shall be paid in quarterly installments and shall
 commence as of the first day of the calendar quarter next following the latest of (a) the date of the Outside Director ceases Service or (b) the
date the Outside Director attains age 55 or (c) the Effective Date of the Plan. Payments of Retirement Income will continue for a period of calendar
years which is equal to the number of years of Service of the Outside Director or until his death, whichever first occurs, subject to section 7. below.</LI></P>
<U><P ALIGN="JUSTIFY">&nbsp;</P>
</U><P ALIGN="CENTER">IV-26</P>
<P ALIGN="JUSTIFY">&nbsp;</P>
<P>&nbsp;</P>
<U><P ALIGN="JUSTIFY"><LI>Increases in Retirement Income</U>. If the Annual Retainer and/or Meeting Fees paid to active Outside Directors are
increased to an amount higher than that in effect as of the date an Outside Director ceased his Service, the Corporation may, in its sole
discretion, prospectively increase the amount of Retirement Income to be paid, or then being paid, to a retired Outside Director.</LI></P>
<U><LI>Death Benefit for Spouse</U>. In the event of the death of a retired Outside Director on or after the Effective Date of the Plan, the
surviving spouse shall be entitled to receive the same Vested Benefits that the Outside Director would have received had the Outside Director
 survived.</LI>
<P ALIGN="JUSTIFY">In the event of the death of an active Outside Director on or after the Effective Date of the Plan, the surviving spouse
shall be entitled to receive the same Vested Benefits that the Outside Director would have received had the Outside Director retired on the
date of death.</P>
<P ALIGN="JUSTIFY">Such Vested Benefits payments shall continue until the first to occur of (a) the death of the surviving spouse, or (b)
 the expiration of the duration of the Retirement Income as set forth in section 5. hereinabove as if the Outside Director had survived.</P>
<U><P ALIGN="JUSTIFY"><LI>Removal for Cause</U>. In the event an Outside Director is removed for cause, as determined by the Board, there
shall be no payments under the Plan. For purposes of this provision, "cause" shall mean any act or omission (a) in breach of the Outside
Director's duty of loyalty to the Corporation or its shareholders, (b) not in good faith or involving a knowing violation of law, or (c)
resulting in receipt by the Outside Director of an improper personal benefit.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Obligations of Retired Outside Directors</U>. Anything in the Plan to the contrary notwithstanding, Retirement
Income shall commence, and continue to be paid, only if the Outside Director remains available to provide advice and counsel to the Corporation,
 and does not engage in business activity with other firms which the Corporation deems is competitive to its interests following such resignation
 or retirement; provided, however, that the obligations set forth hereinabove shall be deemed waived in the event of a Change of Control.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Provision of Benefits</U>. All benefits payable hereunder shall be provided from the general assets of the Corporation.
No Outside Director shall acquire any interest in any specific assets of the Corporation by reason of this Plan.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Amendment and Termination</U>. The Corporation reserves the right to terminate this Plan or amend this Plan in any
respect at any time, provided, however, that no termination or amendment may reduce the Vested Benefits of any Outside Director.</LI></P>
<U><P ALIGN="JUSTIFY"><LI>Arbitration</U>. The parties agree that any dispute or claim concerning this Plan or the terms thereof, including
 whether such dispute or claim is arbitrable, will be settled by arbitration. The arbitration proceedings shall be conducted under the
Commercial Arbitration Rules of the American Arbitration Association in effect at the time a demand for arbitration under the rules is
 made. Either party shall make a demand for arbitration by giving a demand in writing to the other party.</LI></P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-27</P>
<P>&nbsp;</P>
<P ALIGN="JUSTIFY">The parties may agree upon one arbitrator, but in the event that they cannot agree, there shall be three, one named
in writing by each of the parties and a third chosen by the two arbitrators. Should either party refuse or neglect to join in the appointment
 of the arbitrator(s) or to furnish the arbitrator(s) with any papers or information demanded, the arbitrator(s) are empowered by both parties
to proceed ex parte.</P>
<P ALIGN="JUSTIFY">Arbitration shall take place in the Borough of New Providence, State of New Jersey, and the hearing before the arbitrator(s)
of the matter to be arbitrated shall be at the time and place within said Borough as is selected by the arbitrator(s).</P>
<P ALIGN="JUSTIFY">At the hearing, any relevant evidence may be presented by either party, and the formal rules of evidence and discovery
applicable to judicial proceedings shall not be applicable. Evidence may be admitted or excluded in the sole discretion of the arbitrator(s).
 Said arbitrator(s) shall hear and determine the matter and shall execute and acknowledge their binding award in writing and cause a copy
thereof to be delivered to each of the parties.</P>
<P>The decision of the arbitrator(s) including determination of amount of any damages suffered shall be exclusive, final and binding upon
 both parties, their heirs, executors, administrators, successors, and assigns.</P>
<P>A judgment confirming the award of the arbitrator(s) may be rendered by any court having jurisdiction; or such court may vacate, modify,
or correct the award in accordance with the prevailing law of the State of New Jersey.</P>
<P>The costs of such arbitration shall be borne by the Corporation.</P>
<P>To the extent that any language contained in this arbitration clause shall be inconsistent with any provision of NJS 2A:24-1 et seq or
 any provision of the Commercial Arbitration Rules referred to herein, it is the intention of the parties hereto that the subsequent
inconsistent provision of this clause shall control. &#9;Notwithstanding anything contrary in this Plan, this section is in no way an
attempt to limit discovery which shall be at the sole discretion and prior approval of the arbitrator(s) and his (their) rulings on
discovery shall be binding; however, he (they) is (are) to be guided by the most expeditious manner in resolving disputes under this Plan.</P>
<U><LI>Attorneys' Fees</U>. In the event that the Outside Director shall be the prevailing party in any arbitration or any action at
 law or in equity to enforce an arbitration award, the Corporation shall pay the Outside Director all costs, expenses and reasonable
attorneys' fees incurred therein by such Outside Director including, without limitation, such costs, expenses and fees on any appeals.</LI>
<U><LI>Miscellaneous</U>. Nothing herein contained shall be deemed to give to any Outside Director the right to be retained as a
Director nor shall it interfere with the Outside Director's right to terminate his directorship at any time.</LI></OL>

<P>No benefit payable hereunder shall be subject to alienation or assignment.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-28</P>
<P>The retirement benefits herein contained are in addition to any other award, arrangement, contract or benefits, if any, that
any Outside Director may have by virtue of service for the Corporation, unless and to the extent that any such other award,
arrangement, contract or benefit provides otherwise.</P>
<P>15.&#9;This Plan shall be construed according to the laws of the State of New Jersey.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>Revised 2/93</P>
</FONT><FONT SIZE=2><P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-29</P></FONT></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12
<SEQUENCE>6
<TEXT>

<HTML>
<HEAD>
<TITLE>Exhibit 12</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="Garamond"><P>Exhibit 12.1&#9;&#9;Computation of Ratio of Earnings to Fixed Charges</P>
<P>&nbsp;</P>
<P>&nbsp;</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=935>
<TR><TD WIDTH="26%" VALIGN="TOP" HEIGHT=13>
<P></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=13>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">1999 </U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=13>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">1998 </U></FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=13>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">1997 </U></FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=13>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">1996 </U></FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=13>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">1995 </U></FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=13>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">1994 </U></FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP" HEIGHT=25>
<FONT FACE="Garamond" SIZE=3><P>Earnings before taxes</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=25>
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$173,300 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=25>
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$464,400 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=25>
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$104,900 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=25>
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$102,700 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=25>
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$123,500 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=25>
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$104,100 </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Add(Deduct) Fixed Charges</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">    24,200 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">31,400 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">38,200 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">33,500 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">31,500 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">23,200 </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Undistributed earnings of less than 50% owned companies carried at equity&#9;&#9;</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">(2,700) </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">(800) </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">(500) </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">(700) </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">(800) </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">(400) </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP" HEIGHT=19>
<FONT FACE="Garamond" SIZE=3><P>Interest capitalized</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=19>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">0</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=19>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">0</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=19>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">0</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=19>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">0</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=19>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">0</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=19>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">(200</U>) </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP" HEIGHT=23>
<FONT FACE="Garamond" SIZE=3><P>Earnings available for fixed charges</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=23>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$194,800</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=23>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$495,000</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=23>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$142,600</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=23>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$135,500</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=23>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$154,200</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=23>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$126,700</U> </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Fixed charges:</P>
<P>Interest, including amounts capitalized</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">  </P>
<P ALIGN="RIGHT">19,300 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">26,400 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">32,900 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">26,400 </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">24,200 </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">16,500 </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP" HEIGHT=59>
<FONT FACE="Garamond" SIZE=3><P>Proportion of rent expense deemed to represent interest factor</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=59>
<FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<U><P ALIGN="RIGHT">4,900</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=59>
<U><FONT FACE="Garamond" SIZE=3><P>&nbsp;</P>
<P ALIGN="RIGHT">5,000</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=59>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">5,300</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=59>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">7,100</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=59>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">7,300</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=59>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">6,700</U> </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP" HEIGHT=20>
<FONT FACE="Garamond" SIZE=3><P>Fixed Charges</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=20>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$ 24,200</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=20>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$ 31,400</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=20>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$ 38,200</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=20>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$ 33,500</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=20>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$ 31,500</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=20>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">$ 23,200</U> </FONT></TD>
</TR>
<TR><TD WIDTH="26%" VALIGN="TOP" HEIGHT=43>
<FONT FACE="Garamond" SIZE=3><P>&nbsp;</P>
<P>Ratio of earnings to fixed charges</FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=43>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">12.42</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=43>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">15.76</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=43>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">3.73</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=43>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">4.04</U> </FONT></TD>
<TD WIDTH="13%" VALIGN="TOP" HEIGHT=43>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">4.89</U> </FONT></TD>
<TD WIDTH="12%" VALIGN="TOP" HEIGHT=43>
<U><FONT FACE="Garamond" SIZE=3><P ALIGN="RIGHT">&nbsp;</P>
<P ALIGN="RIGHT">5.46</U> </FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-30</P></FONT></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21
<SEQUENCE>7
<TEXT>

<HTML>
<HEAD>
<TITLE>Ex2199</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="Garamond"><P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P>Exhibit 21</P>
<P>Parents and Subsidiaries of Registrant</P>
<P>The following table lists, as of December 31, 1998, the company and its significant subsidiaries and indicates the jurisdiction of organization of each subsidiary and the percentage of voting securities owned by the immediate parent of each subsidiary.
</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD WIDTH="57%" VALIGN="TOP">
<P><FONT SIZE=3>&nbsp;</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">Where</P>
<U><P ALIGN="CENTER">Incorporated</U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">% of</P>
<U><P ALIGN="CENTER">Voting Stock</U></FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>C. R. Bard, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>New Jersey</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">(Registrant)</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Bard Access Systems, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Utah</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Bard Canada Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Canada</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Vas-Cath, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Canada</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard Reynosa S.A. de C.V.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Mexico</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Bard Cardiopulmonary, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Delaware</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Bard Devices, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Delaware</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Davol Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Delaware</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Davol Surgical Innovations, S.A. de C.V.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Mexico</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Bard Holdings Limited</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>England</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard Financial Services Ltd.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>England</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard Limited</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>England</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>   Bard Sendirian Berhad</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Malaysia</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">85</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>   Bard Sweden AB</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Sweden</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>    Bard Medical Systems</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Norway</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>    Bard Medical Systems</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Finland</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Bard Implants, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Delaware</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Bard International, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Delaware</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard Australia Pty. Ltd.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Australia</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard Singapore</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Singapore</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP" HEIGHT=18>
<FONT FACE="Garamond" SIZE=3><P>  Bard Pacific Health Care Company Ltd.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=18>
<FONT FACE="Garamond" SIZE=3><P>Taiwan</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=18>
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">51</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Productos Bard de Mexico S.A. de C.V.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Mexico</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP" HEIGHT=17>
<FONT FACE="Garamond" SIZE=3><P> Bard Shannon Limited&#9;</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP" HEIGHT=17>
<FONT FACE="Garamond" SIZE=3><P>Ireland</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP" HEIGHT=17>
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Angiomed GmbH</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Germany</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard Benelux N.V.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Belgium</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard Dublin ITC</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Ireland</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard de Espana, S.A.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Spain</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>   Bard Portugal LDA</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Portugal</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard European Distribution Center N.V.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Belgium</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Bard S.P.A.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Italy</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  C. R. Bard GmbH</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Germany</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>&#9;&#9;&#9;&#9;&#9; </P>
<P>&#9;&#9;&#9;&#9;</P>
<P ALIGN="CENTER">IV-31</P>
<P ALIGN="CENTER">C. R. BARD, INC. AND SUBSIDIARIES</P>
<P>Exhibit 21</P>
<P>Parents and Subsidiaries of Registrant (continued)</P></FONT>
<TABLE CELLSPACING=0 BORDER=0 CELLPADDING=7 WIDTH=638>
<TR><TD WIDTH="57%" VALIGN="TOP">
<P><FONT SIZE=3>&nbsp;</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">Where</P>
<U><P ALIGN="CENTER">Incorporated</U></FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">% of</P>
<U><P ALIGN="CENTER">Voting Stock</U></FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Laboratories Bard S.A.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>France</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>   Cardial S.A.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>France</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>  Promur-Productos Medicos e Urologicos Limitada</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Brazil</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> BCP Puerto Rico, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Delaware</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> BCR Delaware, Inc</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Delaware</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> BJL KK</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Japan</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Dymax Corporation</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Pennsylvania</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Endomatrix</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Massachusetts</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> IMPRA, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Arizona</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> MedChem Products, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Massachusetts</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Productos Para el Cuidada de la Salud, S.A. de C.V.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Mexico</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
<TR><TD WIDTH="57%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P> Roberts Laboratories, Inc.</FONT></TD>
<TD WIDTH="23%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P>Arizona</FONT></TD>
<TD WIDTH="21%" VALIGN="TOP">
<FONT FACE="Garamond" SIZE=3><P ALIGN="CENTER">100</FONT></TD>
</TR>
</TABLE>

<FONT FACE="Garamond"><P>&#9;&#9;&#9;&#9;&#9; </P>
<P>The Consolidated Financial Statements include the accounts of the Registrant and all its wholly owned subsidiaries.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-32</P></FONT></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23
<SEQUENCE>8
<TEXT>

<HTML>
<HEAD>
<TITLE>CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS</TITLE>
</HEAD>
<BODY LINK="#0000ff" VLINK="#800080">

<FONT FACE="Book Antiqua"><P>Exhibit 23</P>
<U><P ALIGN="CENTER">&nbsp;</P>
</FONT><P ALIGN="CENTER">CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS</P>
<P ALIGN="CENTER">&nbsp;</P>
<P ALIGN="CENTER">&nbsp;</P>
</U><P>To C. R. Bard, Inc.:</P>
<P>&nbsp;</P>
<P>As independent public accountants, we hereby consent to the incorporation
by reference of our report dated January 26, 2000,
included in this Form 10-K, into C. R. Bard, Inc.'s previously filed
Registration Statements (i) on Form S-8 for the Employees'
 Retirement Savings Plan of C. R. Bard, Inc., Registration No. 333-30217,
(ii) on Form S-3, Registration No. 333-05997, (iii) on
Form S-8 for the 1990 Employee Stock Option Plan, as amended, Registration
No. 333-35544, (iv) on Form S-8 for the C. R. Bard,
Inc. 1988 Directors Stock Award Plan, as amended, Registration No.'s
 333-64874 and 333-51793, (v) on Form S-8 for the 1993 Long-term
Incentive Plan of C. R. Bard, Inc., as amended, Registration No.'s
33-64874, 333-07189, 333-51793 and 333-78089, (vi) on Form S-8 for
 the 1998 Employee Stock Purchase Plan of C. R. Bard, Inc., Registration
No. 333-51793, (vii) on Form S-8 for the C. R. Bard, Inc.
Management Stock Purchase Plan, Registration No. 333-69857 and (viii) on
Form S-8 for the MedChem Products, Inc. 1994 Stock Option
 Plan, MedChem Products, Inc. 1993 Stock Option Plan, MedChem Products,
Inc. 1993 Spin-off Stock Option Plan, MedChem Products,
Inc. 1993 Director Stock Option Plan, MedChem Products, Inc. amended and
restated Stock Option Plan, all formerly maintained by
MedChem Products, Inc., Registration No. 33-63147.</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>Roseland, New Jersey</P>
<P>March 27, 2000</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P>&nbsp;</P>
<P ALIGN="CENTER">IV-33</P></BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-27
<SEQUENCE>9
<TEXT>

<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                           17300
<SECURITIES>                                     78600
<RECEIVABLES>                                   212900
<ALLOWANCES>                                      8500
<INVENTORY>                                     204000
<CURRENT-ASSETS>                                529100
<PP&E>                                          292600
<DEPRECIATION>                                  122900
<TOTAL-ASSETS>                                 1126400
<CURRENT-LIABILITIES>                           352500
<BONDS>                                         158400
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         12700
<OTHER-SE>                                      627000
<TOTAL-LIABILITY-AND-EQUITY>                   1126400
<SALES>                                        1036500
<TOTAL-REVENUES>                               1036500
<CGS>                                           462300
<TOTAL-COSTS>                                   846600
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               19300
<INCOME-PRETAX>                                 173300
<INCOME-TAX>                                     55200
<INCOME-CONTINUING>                             118100
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    118100
<EPS-BASIC>                                     2.31
<EPS-DILUTED>                                     2.28


</TABLE>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
